R6 Ballot (2nd Draft)
TerminologyPublish-box (todo)
Orders and Observations  Work Group |
Maturity Level: 1 | Draft | Use Context: Country: World, Not Intended for Production use |
Official URL: http://hl7.org/fhir/ValueSet/observation-codes
|
Version: 6.0.0-ballot2 | |||
| draft as of 2024-08-12 | Computable Name: LOINCCodes | |||
| Flags: Experimental | OID: 2.16.840.1.113883.4.642.3.396 | |||
This value set is used in the following places:
This value set includes all LOINC codes
Generated Narrative: ValueSet observation-codes
Last updated: 2024-08-12T16:52:12.437+08:00
Profile: Shareable ValueSet
http://loinc.org
This expansion generated 12 Aug 2024
Generated Narrative: ValueSet
Last updated: 2024-08-11T21:29:24.416+08:00
Profile: Shareable ValueSet
Expansion based on Loinc v2.77
This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
| Code | System | Display |
| 100000-9 |
http://loinc.org | Health informatics pioneer and the father of LOINC |
| 100001-7 |
http://loinc.org | Health informatics pioneer and cofounder of LOINC |
| 100002-5 |
http://loinc.org | Specimen care is maintained |
| 100003-3 |
http://loinc.org | Team communication is maintained throughout care |
| 100004-1 |
http://loinc.org | Demonstrates knowledge of the expected psychosocial responses to the procedure |
| 100005-8 |
http://loinc.org | Demonstrates knowledge of nutritional management related to the procedure |
| 100006-6 |
http://loinc.org | Demonstrates knowledge of medication management |
| 100007-4 |
http://loinc.org | Demonstrates knowledge of pain management |
| 10000-8 |
http://loinc.org | R wave duration in lead AVR |
| 100008-2 |
http://loinc.org | Demonstrates knowledge of wound management |
| 100009-0 |
http://loinc.org | Demonstrates knowledge of the procedure and expected results |
| 100010-8 |
http://loinc.org | No injury related to procedure equipment, medical supplies, or instrumentation |
| 100011-6 |
http://loinc.org | No injury related to an electrical source |
| 100012-4 |
http://loinc.org | Participates in decisions affecting the patient's plan of care |
| 100013-2 |
http://loinc.org | Participates in the discharge process |
| 100014-0 |
http://loinc.org | Psychosocial health is maintained at or improved from baseline |
| 100015-7 |
http://loinc.org | No injury related to positioning due to care or procedure |
| 10001-6 |
http://loinc.org | R wave duration in lead I |
| 100016-5 |
http://loinc.org | No injury related to a laser source |
| 100017-3 |
http://loinc.org | Perioperative nursing data set outcomes panel [PNDS] |
| 100018-1 |
http://loinc.org | Hospice care Note |
| 100019-9 |
http://loinc.org | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100020-7 |
http://loinc.org | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100021-5 |
http://loinc.org | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100022-3 |
http://loinc.org | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100023-1 |
http://loinc.org | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 10002-4 |
http://loinc.org | R wave duration in lead II |
| 100024-9 |
http://loinc.org | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100025-6 |
http://loinc.org | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100026-4 |
http://loinc.org | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100027-2 |
http://loinc.org | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100028-0 |
http://loinc.org | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100029-8 |
http://loinc.org | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method |
| 100030-6 |
http://loinc.org | Axis I: Temporal aspects score [Mainz Pain Staging System] |
| 100031-4 |
http://loinc.org | Axis II: Spatial aspects score [Mainz Pain Staging System] |
| 10003-2 |
http://loinc.org | R wave duration in lead III |
| 100032-2 |
http://loinc.org | Axis III: Drug taking behavior score [Mainz Pain Staging System] |
| 100033-0 |
http://loinc.org | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] |
| 100034-8 |
http://loinc.org | Provider of automated external defibrillator use |
| 100035-5 |
http://loinc.org | Exam finding location of Chest |
| 100036-3 |
http://loinc.org | Exam finding location of Lung |
| 100037-1 |
http://loinc.org | Patient contact disposition EMS unit |
| 100038-9 |
http://loinc.org | Patient evaluation disposition EMS unit |
| 100039-7 |
http://loinc.org | Crew disposition for patient care EMS unit |
| 10004-0 |
http://loinc.org | R wave duration in lead V1 |
| 100040-5 |
http://loinc.org | Patient transport disposition EMS unit |
| 100041-3 |
http://loinc.org | Aminoglycoside [Susceptibility] |
| 100042-1 |
http://loinc.org | Atovaquone [Susceptibility] |
| 100043-9 |
http://loinc.org | Azithromycin+Ethambutol [Susceptibility] |
| 100044-7 |
http://loinc.org | Cefcapene [Susceptibility] |
| 100045-4 |
http://loinc.org | Cefozopran [Susceptibility] |
| 100046-2 |
http://loinc.org | Cefquinome [Susceptibility] |
| 100047-0 |
http://loinc.org | Cefteram [Susceptibility] |
| 100048-8 |
http://loinc.org | Clarithromycin+Ethambutol [Susceptibility] |
| 100049-6 |
http://loinc.org | Eravacycline [Susceptibility] |
| 100050-4 |
http://loinc.org | Erythromycin+Ethambutol [Susceptibility] |
| 100051-2 |
http://loinc.org | Ethambutol+rifAMPin [Susceptibility] |
| 100052-0 |
http://loinc.org | Flomoxef [Susceptibility] |
| 100053-8 |
http://loinc.org | Fluoroquinolone [Susceptibility] |
| 100054-6 |
http://loinc.org | Gamithromycin [Susceptibility] |
| 100055-3 |
http://loinc.org | Optochin [Susceptibility] |
| 100056-1 |
http://loinc.org | Panipenem [Susceptibility] |
| 10005-7 |
http://loinc.org | R wave duration in lead V2 |
| 100057-9 |
http://loinc.org | Prothionamide [Susceptibility] |
| 100058-7 |
http://loinc.org | Prulifloxacin [Susceptibility] |
| 100059-5 |
http://loinc.org | Rifapentine [Susceptibility] |
| 100060-3 |
http://loinc.org | Tildipirosin [Susceptibility] |
| 100061-1 |
http://loinc.org | Tosufloxacin [Susceptibility] |
| 100062-9 |
http://loinc.org | Standard Dermatology Outcome Measures panel |
| 100063-7 |
http://loinc.org | Primary skin concern |
| 100064-5 |
http://loinc.org | Itch severity Reporting Period - Reported |
| 10006-5 |
http://loinc.org | R wave duration in lead V3 |
| 100065-2 |
http://loinc.org | Satisfied with treatment |
| 100066-0 |
http://loinc.org | Specular microscopy panel |
| 100067-8 |
http://loinc.org | Eye Image magnification |
| 100068-6 |
http://loinc.org | Right eye Fixation point [Angle] |
| 100069-4 |
http://loinc.org | Left eye Fixation point [Angle] |
| 100070-2 |
http://loinc.org | Right cornea Cell density |
| 100071-0 |
http://loinc.org | Left cornea Cell density |
| 100072-8 |
http://loinc.org | Right cornea Coefficient of variation |
| 10007-3 |
http://loinc.org | R wave duration in lead V4 |
| 100073-6 |
http://loinc.org | Left cornea Coefficient of variation |
| 100074-4 |
http://loinc.org | Right cornea Hexagonality |
| 100075-1 |
http://loinc.org | Left cornea Hexagonality |
| 100076-9 |
http://loinc.org | Right cornea Endothelial cells counted |
| 100077-7 |
http://loinc.org | Left cornea Endothelial cells counted |
| 100078-5 |
http://loinc.org | Right cornea Endothelial cell area.min |
| 100079-3 |
http://loinc.org | Left cornea Endothelial cell area.min |
| 100080-1 |
http://loinc.org | Right cornea Endothelial cell area.max |
| 10008-1 |
http://loinc.org | R wave duration in lead V5 |
| 100081-9 |
http://loinc.org | Left cornea Endothelial cell area.max |
| 100082-7 |
http://loinc.org | Right cornea Endothelial cell area.mean |
| 100083-5 |
http://loinc.org | Left cornea Endothelial cell area.mean |
| 100084-3 |
http://loinc.org | Right cornea Cell area.standard deviation |
| 100085-0 |
http://loinc.org | Left cornea Cell area.standard deviation |
| 100086-8 |
http://loinc.org | Right cornea Type of Analysis method by Specular microscopy |
| 100087-6 |
http://loinc.org | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot |
| 100088-4 |
http://loinc.org | Taenia solium larva Ab bands panel - Serum by Immunoblot |
| 100089-2 |
http://loinc.org | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot |
| 1000-9 |
http://loinc.org | DBG Ab [Presence] in Serum or Plasma from Blood product unit |
| 100090-0 |
http://loinc.org | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot |
| 100091-8 |
http://loinc.org | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay |
| 100092-6 |
http://loinc.org | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot |
| 100093-4 |
http://loinc.org | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot |
| 100094-2 |
http://loinc.org | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot |
| 100095-9 |
http://loinc.org | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
| 100096-7 |
http://loinc.org | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot |
| 100097-5 |
http://loinc.org | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot |
| 100098-3 |
http://loinc.org | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot |
| 10009-9 |
http://loinc.org | R wave duration in lead V6 |
| 100099-1 |
http://loinc.org | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot |
| 100100-7 |
http://loinc.org | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay |
| 100101-5 |
http://loinc.org | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot |
| 100102-3 |
http://loinc.org | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
| 100103-1 |
http://loinc.org | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot |
| 100104-9 |
http://loinc.org | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot |
| 100105-6 |
http://loinc.org | Filaria IgG and IgM panel - Serum |
| 100106-4 |
http://loinc.org | Filaria IgG Ab [Presence] in Serum by Immunoassay |
| 10010-7 |
http://loinc.org | R' wave amplitude in lead AVF |
| 100107-2 |
http://loinc.org | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay |
| 100108-0 |
http://loinc.org | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 100109-8 |
http://loinc.org | Leishmania sp Ab bands panel - Serum by Immunoblot |
| 100110-6 |
http://loinc.org | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot |
| 100111-4 |
http://loinc.org | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot |
| 100112-2 |
http://loinc.org | Fasciola sp Ab bands panel - Serum by Immunoblot |
| 100113-0 |
http://loinc.org | Helicobacter pylori Ab panel - Serum |
| 100114-8 |
http://loinc.org | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot |
| 10011-5 |
http://loinc.org | R' wave amplitude in lead AVL |
| 100115-5 |
http://loinc.org | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot |
| 100116-3 |
http://loinc.org | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot |
| 100117-1 |
http://loinc.org | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot |
| 100118-9 |
http://loinc.org | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot |
| 100119-7 |
http://loinc.org | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot |
| 100120-5 |
http://loinc.org | Chlamydia trachomatis Ab panel - Serum |
| 100121-3 |
http://loinc.org | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay |
| 100122-1 |
http://loinc.org | Chlamydophila pneumoniae Ab panel - Serum |
| 10012-3 |
http://loinc.org | R' wave amplitude in lead AVR |
| 100123-9 |
http://loinc.org | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay |
| 100124-7 |
http://loinc.org | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay |
| 100125-4 |
http://loinc.org | Chlamydophila psittaci Ab panel - Serum |
| 100126-2 |
http://loinc.org | Bordetella pertussis Ab.IgG panel - Serum |
| 100127-0 |
http://loinc.org | Campylobacter sp Ab panel - Serum |
| 100128-8 |
http://loinc.org | Cryptococcus sp Ag panel - Serum |
| 100129-6 |
http://loinc.org | Schistosoma sp Ab [Titer] in Serum by Hemagglutination |
| 100130-4 |
http://loinc.org | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot |
| 10013-1 |
http://loinc.org | R' wave amplitude in lead I |
| 100131-2 |
http://loinc.org | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot |
| 100132-0 |
http://loinc.org | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot |
| 100133-8 |
http://loinc.org | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot |
| 100134-6 |
http://loinc.org | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot |
| 100135-3 |
http://loinc.org | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot |
| 100136-1 |
http://loinc.org | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot |
| 100137-9 |
http://loinc.org | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot |
| 100138-7 |
http://loinc.org | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot |
| 100139-5 |
http://loinc.org | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot |
| 100140-3 |
http://loinc.org | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot |
| 100141-1 |
http://loinc.org | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot |
| 100142-9 |
http://loinc.org | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot |
| 100143-7 |
http://loinc.org | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot |
| 100144-5 |
http://loinc.org | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot |
| 100145-2 |
http://loinc.org | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot |
| 100146-0 |
http://loinc.org | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot |
| 100147-8 |
http://loinc.org | Toxoplasma gondii Ab bands panel - Serum by Immunoblot |
| 100148-6 |
http://loinc.org | Schistosoma sp Ab bands panel - Serum by Immunoblot |
| 10014-9 |
http://loinc.org | R' wave amplitude in lead II |
| 100149-4 |
http://loinc.org | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma |
| 100150-2 |
http://loinc.org | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma |
| 100151-0 |
http://loinc.org | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma |
| 100152-8 |
http://loinc.org | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
| 100153-6 |
http://loinc.org | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
| 100154-4 |
http://loinc.org | Specimen collection supervision level |
| 100155-1 |
http://loinc.org | Left cornea Type of Analysis method by Specular microscopy |
| 10015-6 |
http://loinc.org | R' wave amplitude in lead III |
| 100156-9 |
http://loinc.org | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection |
| 100157-7 |
http://loinc.org | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing |
| 100158-5 |
http://loinc.org | Microalbumin [Mass/volume] in Urine collected for unspecified duration |
| 100159-3 |
http://loinc.org | Knee Society Score pre-op panel [Knee Society Score] |
| 100160-1 |
http://loinc.org | Knee replacement |
| 100161-9 |
http://loinc.org | Charnley Functional Classification |
| 100162-7 |
http://loinc.org | Knee alignment W standing X-ray measured |
| 100163-5 |
http://loinc.org | Knee medial AndOr lateral instability W full extension |
| 10016-4 |
http://loinc.org | R' wave amplitude in lead V1 |
| 100164-3 |
http://loinc.org | Knee AP instability W 90 degree flexion |
| 100165-0 |
http://loinc.org | Knee range of motion |
| 100166-8 |
http://loinc.org | Flexion contracture range of Knee |
| 100167-6 |
http://loinc.org | Extensor lag range of Knee |
| 100168-4 |
http://loinc.org | Knee pain severity with level walking |
| 100169-2 |
http://loinc.org | Knee pain severity with stairs or inclines |
| 1001-7 |
http://loinc.org | DBG Ab [Presence] in Serum or Plasma from Donor |
| 100170-0 |
http://loinc.org | Knee feels normal |
| 100171-8 |
http://loinc.org | Satisfaction with level of knee pain while sitting |
| 10017-2 |
http://loinc.org | R' wave amplitude in lead V2 |
| 100172-6 |
http://loinc.org | Satisfaction with level of knee pain while lying in bed |
| 100173-4 |
http://loinc.org | Satisfaction with knee function while getting out of bed |
| 100174-2 |
http://loinc.org | Satisfaction with knee function while performing light household duties |
| 100175-9 |
http://loinc.org | Satisfaction with knee function while performing recreational activities |
| 100176-7 |
http://loinc.org | Expect surgery to relieve pain |
| 100177-5 |
http://loinc.org | Expect surgery will improve ability to perform activities of daily living |
| 100178-3 |
http://loinc.org | Expect surgery will improve ability to perform leisure, recreational, or sports activities |
| 100179-1 |
http://loinc.org | Walk without assistive mobility devices |
| 10018-0 |
http://loinc.org | R' wave amplitude in lead V3 |
| 100180-9 |
http://loinc.org | Assistive mobility devices used |
| 100181-7 |
http://loinc.org | Assistive mobility devices used due to health condition |
| 100182-5 |
http://loinc.org | Duration of standing before sitting due to knee discomfort |
| 100183-3 |
http://loinc.org | Duration of walking before stopping due to knee discomfort |
| 100184-1 |
http://loinc.org | How bothersome is knee when walking on an uneven surface |
| 100185-8 |
http://loinc.org | How bothersome is knee when turning or pivoting leg |
| 100186-6 |
http://loinc.org | How bothersome is knee when climbing up or down a flight of stairs |
| 100187-4 |
http://loinc.org | How bothersome is knee when getting up from a low seat without armrests |
| 100188-2 |
http://loinc.org | How bothersome is knee when getting into or out of a car |
| 100189-0 |
http://loinc.org | How bothersome is knee when moving laterally |
| 100190-8 |
http://loinc.org | How bothersome is knee when climbing a ladder or step stool |
| 100191-6 |
http://loinc.org | How bothersome is knee when carrying a bag for one block |
| 100192-4 |
http://loinc.org | How bothersome is knee when squatting |
| 100193-2 |
http://loinc.org | How bothersome is knee when kneeling |
| 100194-0 |
http://loinc.org | How bothersome is knee when running |
| 100195-7 |
http://loinc.org | Pain severity--during activity |
| 100196-5 |
http://loinc.org | Pre-op total score [Knee Society Score] |
| 100197-3 |
http://loinc.org | Exercise activity and pain severity panel |
| 10019-8 |
http://loinc.org | R' wave amplitude in lead V4 |
| 100198-1 |
http://loinc.org | Pre-op objective knee indicators score [Knee Society Score] |
| 100199-9 |
http://loinc.org | Pre-op symptoms score [Knee Society Score] |
| 100200-5 |
http://loinc.org | Pre-op patient expectations score [Knee Society Score] |
| 100201-3 |
http://loinc.org | Pre-op functional activities score [Knee Society Score] |
| 100202-1 |
http://loinc.org | Pre-op discretionary knee activities score [Knee Society Score] |
| 100203-9 |
http://loinc.org | Knee Society Score post-op panel [Knee Society Score] |
| 100204-7 |
http://loinc.org | Accuracy of pre-surgery expectations of pain relief |
| 100205-4 |
http://loinc.org | Accuracy of pre-surgery expectations to perform activities of daily living |
| 10020-6 |
http://loinc.org | R' wave amplitude in lead V5 |
| 100206-2 |
http://loinc.org | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities |
| 100207-0 |
http://loinc.org | Post-op total score [Knee Society Score] |
| 100208-8 |
http://loinc.org | Post-op objective knee indicators score [Knee Society Score] |
| 100209-6 |
http://loinc.org | Post-op symptoms score [Knee Society Score] |
| 100210-4 |
http://loinc.org | Post-op patient expectations score [Knee Society Score] |
| 100211-2 |
http://loinc.org | Post-op functional activities score [Knee Society Score] |
| 100212-0 |
http://loinc.org | Post-op discretionary knee activities score [Knee Society Score] |
| 100213-8 |
http://loinc.org | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method |
| 10021-4 |
http://loinc.org | R' wave amplitude in lead V6 |
| 100214-6 |
http://loinc.org | Dental model prior authorization Document |
| 100215-3 |
http://loinc.org | Episode of care medical records Document Transplant surgery |
| 100216-1 |
http://loinc.org | Surgical synoptic report |
| 100217-9 |
http://loinc.org | Synoptic report Narrative Surgical oncology |
| 100218-7 |
http://loinc.org | Surgical oncology of colon cancer synoptic report |
| 100219-5 |
http://loinc.org | Surgical oncology of melanoma cancer synoptic report |
| 100220-3 |
http://loinc.org | Surgical oncology of breast cancer synoptic report |
| 100221-1 |
http://loinc.org | Surgical oncology of thyroid cancer synoptic report |
| 10022-2 |
http://loinc.org | R' wave duration in lead AVF |
| 100222-9 |
http://loinc.org | Surgical oncology of pancreas cancer synoptic report |
| 100223-7 |
http://loinc.org | Physical findings of Retina Narrative |
| 100224-5 |
http://loinc.org | Cardiac left ventricular segmental wall motion by echo panel |
| 100225-2 |
http://loinc.org | Bone density quantitative ultrasound study |
| 100226-0 |
http://loinc.org | Small bowel capsule endoscopy study Document |
| 100227-8 |
http://loinc.org | Colon capsule endoscopy study Document |
| 100228-6 |
http://loinc.org | Upper gastrointestinal capsule endoscopy study Document |
| 100229-4 |
http://loinc.org | Endoscopic ultrasound study Document |
| 10023-0 |
http://loinc.org | R' wave duration in lead AVL |
| 100230-2 |
http://loinc.org | Routine prenatal assessment panel |
| 100231-0 |
http://loinc.org | Endobronchial ultrasound study |
| 100232-8 |
http://loinc.org | Impacts of Events Scale-Revised panel |
| 100233-6 |
http://loinc.org | Reminders brought back feelings about adverse event |
| 100234-4 |
http://loinc.org | Trouble staying asleep |
| 100235-1 |
http://loinc.org | Other things triggered persistent thoughts about adverse event |
| 100236-9 |
http://loinc.org | Felt irritable AndOr angry |
| 100237-7 |
http://loinc.org | Avoided getting upset when unintentionally thought about adverse event |
| 100238-5 |
http://loinc.org | Thought about adverse event unintentionally |
| 100239-3 |
http://loinc.org | Felt as if adverse event did not happen |
| 100240-1 |
http://loinc.org | Avoided reminders of adverse event |
| 100241-9 |
http://loinc.org | Experienced mental images of adverse event |
| 100242-7 |
http://loinc.org | Easily startled |
| 100243-5 |
http://loinc.org | Tried to not think of adverse event |
| 100244-3 |
http://loinc.org | Aware of feelings about adverse event, but did not address them |
| 100245-0 |
http://loinc.org | Feelings about adverse event were numb |
| 100246-8 |
http://loinc.org | Acted or felt the same as during adverse event |
| 100247-6 |
http://loinc.org | Trouble falling asleep |
| 10024-8 |
http://loinc.org | R' wave duration in lead AVR |
| 100248-4 |
http://loinc.org | Waves of strong feelings about adverse event |
| 100249-2 |
http://loinc.org | Tried to remove adverse event from memory |
| 1002-5 |
http://loinc.org | DBG Ab [Presence] in Serum or Plasma |
| 100250-0 |
http://loinc.org | Trouble concentrating |
| 100251-8 |
http://loinc.org | Reminders of adverse event caused physical reactions |
| 100252-6 |
http://loinc.org | Had dreams about adverse event |
| 100253-4 |
http://loinc.org | Felt watchful and on-guard |
| 100254-2 |
http://loinc.org | Tried not to talk about adverse event |
| 10025-5 |
http://loinc.org | R' wave duration in lead I |
| 100255-9 |
http://loinc.org | Total score [Impact of Event Scale-Revised] |
| 100256-7 |
http://loinc.org | Fallen in last 6 months |
| 100257-5 |
http://loinc.org | Feel unsteady when standing or walking |
| 100258-3 |
http://loinc.org | History of fall related injury |
| 100259-1 |
http://loinc.org | Aware of tactile sensations |
| 100260-9 |
http://loinc.org | Easy to describe thoughts AndOr feelings |
| 100261-7 |
http://loinc.org | Critical of own thoughts AndOr feelings |
| 100262-5 |
http://loinc.org | Able to notice distressing thoughts AndOr feelings without having to react |
| 10026-3 |
http://loinc.org | R' wave duration in lead II |
| 100263-3 |
http://loinc.org | Easily distracted |
| 100264-1 |
http://loinc.org | Able to notice thoughts AndOr feelings without being overwhelmed |
| 100265-8 |
http://loinc.org | Aware of dietary intake impact on self |
| 100266-6 |
http://loinc.org | Difficult to describe thoughts AndOr feelings |
| 100267-4 |
http://loinc.org | Aware of auditory stimuli |
| 100268-2 |
http://loinc.org | Able to avoid immediate reaction in difficult situations |
| 100269-0 |
http://loinc.org | Do things without paying attention |
| 100270-8 |
http://loinc.org | Recover quickly from distressing thoughts AndOr images |
| 10027-1 |
http://loinc.org | R' wave duration in lead III |
| 100271-6 |
http://loinc.org | Aware of olfactory stimuli |
| 100272-4 |
http://loinc.org | Aware of visual stimuli |
| 100273-2 |
http://loinc.org | Aware of emotions affect on thoughts AndOr behavior |
| 100274-0 |
http://loinc.org | Observing score [FFMQ] |
| 100275-7 |
http://loinc.org | Describing score [FFMQ] |
| 100276-5 |
http://loinc.org | Acting with awareness score [FFMQ] |
| 100277-3 |
http://loinc.org | Nonjudging score [FFMQ] |
| 100278-1 |
http://loinc.org | Nonreactivity score [FFMQ] |
| 100279-9 |
http://loinc.org | Total score [FFMQ] |
| 100280-7 |
http://loinc.org | Five Facet Mindfulness Questionnaire panel [FFMQ] |
| 100281-5 |
http://loinc.org | D Ab [Units/volume] in Serum or Plasma |
| 100282-3 |
http://loinc.org | Vaccine exemption certificate |
| 100283-1 |
http://loinc.org | Harris Hip Score panel [Harris Hip Score] |
| 100284-9 |
http://loinc.org | Walking - functional ability |
| 100285-6 |
http://loinc.org | Comfortable seated position |
| 100286-4 |
http://loinc.org | Able to board public transportation |
| 100287-2 |
http://loinc.org | Put on shoes and socks |
| 100288-0 |
http://loinc.org | Absence of deformity score [Harris Hip Score] |
| 10028-9 |
http://loinc.org | R' wave duration in lead V1 |
| 100289-8 |
http://loinc.org | Absence of hip deformity measurements |
| 100290-6 |
http://loinc.org | Range of motion score [Harris Hip Score] |
| 100291-4 |
http://loinc.org | Total score [Harris Hip Score] |
| 100292-2 |
http://loinc.org | Pre-op patient satisfaction score [Knee Society Score] |
| 100293-0 |
http://loinc.org | Hip Flexion range of motion |
| 100294-8 |
http://loinc.org | Hip Abduction range of motion |
| 100295-5 |
http://loinc.org | Hip Adduction range of motion |
| 100296-3 |
http://loinc.org | Hip External rotation range of motion |
| 10029-7 |
http://loinc.org | R' wave duration in lead V2 |
| 100297-1 |
http://loinc.org | Hip Internal rotation range of motion |
| 100298-9 |
http://loinc.org | Repetition count |
| 100299-7 |
http://loinc.org | Post-op patient satisfaction score [Knee Society Score] |
| 100300-3 |
http://loinc.org | End time Unspecified body region |
| 100301-1 |
http://loinc.org | Start time Unspecified body region |
| 100302-9 |
http://loinc.org | Time period start and end panel Unspecified body region |
| 100303-7 |
http://loinc.org | Condition certainty of presence |
| 100304-5 |
http://loinc.org | Flights climbed [#] Reporting Period |
| 10030-5 |
http://loinc.org | R' wave duration in lead V3 |
| 100305-2 |
http://loinc.org | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |
| 100306-0 |
http://loinc.org | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |
| 100307-8 |
http://loinc.org | Behavioral screening elder mistreatment |
| 100308-6 |
http://loinc.org | Need help getting to essential places |
| 100309-4 |
http://loinc.org | Activity support person |
| 100310-2 |
http://loinc.org | Reliability of support person |
| 100311-0 |
http://loinc.org | Need help to make sure there is enough food, medicines or any other things needed in house |
| 100312-8 |
http://loinc.org | Person or persons that makes sure there is enough food, medicines or any other things needed in house |
| 10031-3 |
http://loinc.org | R' wave duration in lead V4 |
| 100313-6 |
http://loinc.org | Need help with household things such as cook meals, help feed, or provide correct medicines each day |
| 100314-4 |
http://loinc.org | Need help with house cleaning or yard work |
| 100315-1 |
http://loinc.org | Need help getting out of bed, showered, or dressed |
| 100316-9 |
http://loinc.org | Need help to make sure bills get paid |
| 100317-7 |
http://loinc.org | Relationship of usual support person for daily activities |
| 100318-5 |
http://loinc.org | Have help with finances AndOr financial decisions |
| 100319-3 |
http://loinc.org | Relationship of financial support person |
| 100320-1 |
http://loinc.org | Financial support person usually asks for permission before making decisions |
| 10032-1 |
http://loinc.org | R' wave duration in lead V5 |
| 100321-9 |
http://loinc.org | Financial support person usually makes good decisions about finances |
| 100322-7 |
http://loinc.org | Have access to paperwork for financial decisions made |
| 100323-5 |
http://loinc.org | Financial support person forged signature |
| 100324-3 |
http://loinc.org | Coercion of financial support person for signing a document in order to get money or possessions |
| 100325-0 |
http://loinc.org | Experienced theft by support person |
| 100326-8 |
http://loinc.org | Money spent or property sold without permission |
| 100327-6 |
http://loinc.org | Stranger forged signature for financial gain |
| 100328-4 |
http://loinc.org | Stranger forced document signature for financial gain |
| 100329-2 |
http://loinc.org | Feared for safety due to verbal attack |
| 1003-3 |
http://loinc.org | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
| 100330-0 |
http://loinc.org | Felt humiliated due to ridicule |
| 100331-8 |
http://loinc.org | Coerced to do something |
| 100332-6 |
http://loinc.org | Ignored by close friend or relative for extended period |
| 100333-4 |
http://loinc.org | Physically hit or threatened |
| 100334-2 |
http://loinc.org | Been physically hurt with some degree of injury |
| 100335-9 |
http://loinc.org | Coerced sexual activity |
| 100336-7 |
http://loinc.org | Coerced touching of private body parts of self or others |
| 100337-5 |
http://loinc.org | Coerced to undress or expose private body area |
| 100338-3 |
http://loinc.org | Photographed in any degree of nudity without consent |
| 10033-9 |
http://loinc.org | R' wave duration in lead V6 |
| 100339-1 |
http://loinc.org | Experienced attempted physical restraint |
| 100340-9 |
http://loinc.org | Range of motion panel Hip |
| 100341-7 |
http://loinc.org | Rubella virus IgG Ab index [Units/volume] in Serum and CSF |
| 100342-5 |
http://loinc.org | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry |
| 100343-3 |
http://loinc.org | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 100344-1 |
http://loinc.org | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 100345-8 |
http://loinc.org | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection |
| 100346-6 |
http://loinc.org | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG |
| 10034-7 |
http://loinc.org | S wave amplitude in lead AVF |
| 100347-4 |
http://loinc.org | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG |
| 100348-2 |
http://loinc.org | Model for end-stage liver disease sodium score |
| 100349-0 |
http://loinc.org | US.doppler Penis vessels W vasodilator IV |
| 100350-8 |
http://loinc.org | Sesamum indicum 1 IgE Ab [Units/volume] in Serum |
| 100351-6 |
http://loinc.org | Pioglitazone [Presence] in Serum or Plasma |
| 100352-4 |
http://loinc.org | Rosiglitazone [Presence] in Serum or Plasma |
| 100353-2 |
http://loinc.org | Norwalk Community Health Center Screening Tool [NCHC] |
| 10035-4 |
http://loinc.org | S wave amplitude in lead AVL |
| 100354-0 |
http://loinc.org | Frequency of participating in multi-modal communication without assistance |
| 100355-7 |
http://loinc.org | Frequency of participating in spoken language expression communication without assistance |
| 100356-5 |
http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection |
| 100357-3 |
http://loinc.org | Naloxone [Presence] in Cord tissue by Screen method |
| 100358-1 |
http://loinc.org | Phentermine [Presence] in Cord tissue by Screen method |
| 100359-9 |
http://loinc.org | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay |
| 100360-7 |
http://loinc.org | Brief Resilience Scale panel [BRS] |
| 100361-5 |
http://loinc.org | Quickly recover from bad events |
| 10036-2 |
http://loinc.org | S wave amplitude in lead AVR |
| 100362-3 |
http://loinc.org | Difficulty making it through stressful events |
| 100363-1 |
http://loinc.org | Easily recover from a stressful event |
| 100364-9 |
http://loinc.org | Difficulty recovering from bad events |
| 100365-6 |
http://loinc.org | Easily recover from difficulties |
| 100366-4 |
http://loinc.org | Lengthy recovery from setbacks |
| 100367-2 |
http://loinc.org | Total Score BRS |
| 100368-0 |
http://loinc.org | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS |
| 100369-8 |
http://loinc.org | NM Thyroid gland Views W Tl-201 IV |
| 10037-0 |
http://loinc.org | S wave amplitude in lead I |
| 100370-6 |
http://loinc.org | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection |
| 100371-4 |
http://loinc.org | Titin Ab [Units/volume] in Serum by Immunoassay |
| 100372-2 |
http://loinc.org | Abiraterone [Mass/volume] in Serum or Plasma |
| 100373-0 |
http://loinc.org | Eucheuma IgG Ab [Units/volume] in Serum |
| 100374-8 |
http://loinc.org | Aloe vera IgG Ab [Units/volume] in Serum |
| 100375-5 |
http://loinc.org | Anise IgG Ab [Units/volume] in Serum |
| 100376-3 |
http://loinc.org | Bambusa vulgaris IgG Ab [Units/volume] in Serum |
| 100377-1 |
http://loinc.org | Goat cheese IgG Ab [Units/volume] in Serum |
| 100378-9 |
http://loinc.org | Sheep cheese IgG Ab [Units/volume] in Serum |
| 100379-7 |
http://loinc.org | Leeks IgG Ab [Units/volume] in Serum |
| 100380-5 |
http://loinc.org | Red cabbage IgG Ab [Units/volume] in Serum |
| 100381-3 |
http://loinc.org | Mentha balsamea Wild IgG Ab [Units/volume] in Serum |
| 100382-1 |
http://loinc.org | FDA package insert REMS addressed risk |
| 100383-9 |
http://loinc.org | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection |
| 100384-7 |
http://loinc.org | Rapeseed IgG Ab [Units/volume] in Serum |
| 100385-4 |
http://loinc.org | Corn salad IgG Ab [Units/volume] in Serum |
| 100386-2 |
http://loinc.org | Rosemary IgG Ab [Units/volume] in Serum |
| 100387-0 |
http://loinc.org | Poppy Seed IgG Ab [Units/volume] in Serum |
| 10038-8 |
http://loinc.org | S wave amplitude in lead II |
| 100388-8 |
http://loinc.org | Cocoa IgG Ab [Units/volume] in Serum |
| 100389-6 |
http://loinc.org | Pistachio IgG Ab [Units/volume] in Serum |
| 100390-4 |
http://loinc.org | Sunflower Seed IgG Ab [Units/volume] in Serum |
| 100391-2 |
http://loinc.org | Dates IgG Ab [Units/volume] in Serum |
| 100392-0 |
http://loinc.org | Duck meat IgG Ab [Units/volume] in Serum |
| 100393-8 |
http://loinc.org | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum |
| 100394-6 |
http://loinc.org | Astacoidea IgG Ab [Units/volume] in Serum |
| 100395-3 |
http://loinc.org | Carob IgG Ab [Units/volume] in Serum |
| 10039-6 |
http://loinc.org | S wave amplitude in lead III |
| 100396-1 |
http://loinc.org | Brassica napus IgG Ab [Units/volume] in Serum |
| 100397-9 |
http://loinc.org | Goat Meat IgG Ab [Units/volume] in Serum |
| 100398-7 |
http://loinc.org | Goose meat IgG Ab [Units/volume] in Serum |
| 100399-5 |
http://loinc.org | Ostrich meat IgG Ab [Units/volume] in Serum |
| 100400-1 |
http://loinc.org | Quail meat IgG Ab [Units/volume] in Serum |
| 100401-9 |
http://loinc.org | Rabbit meat IgG Ab [Units/volume] in Serum |
| 100402-7 |
http://loinc.org | Venison meat IgG Ab [Units/volume] in Serum |
| 100403-5 |
http://loinc.org | Guineafowl IgG Ab [Units/volume] in Serum |
| 10040-4 |
http://loinc.org | S wave amplitude in lead V1 |
| 100404-3 |
http://loinc.org | Horse meat IgG Ab [Units/volume] in Serum |
| 100405-0 |
http://loinc.org | Kefir IgG Ab [Units/volume] in Serum |
| 100406-8 |
http://loinc.org | Butter IgG Ab [Units/volume] in Serum |
| 100407-6 |
http://loinc.org | Camembert cheese IgG Ab [Units/volume] in Serum |
| 100408-4 |
http://loinc.org | Emmental cheese IgG Ab [Units/volume] in Serum |
| 100409-2 |
http://loinc.org | Processed cheese IgG Ab [Units/volume] in Serum |
| 1004-1 |
http://loinc.org | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
| 100410-0 |
http://loinc.org | Curd cheese IgG Ab [Units/volume] in Serum |
| 100411-8 |
http://loinc.org | Sugar Beet IgG Ab [Units/volume] in Serum |
| 10041-2 |
http://loinc.org | S wave amplitude in lead V2 |
| 100412-6 |
http://loinc.org | Chinese cabbage IgG Ab [Units/volume] in Serum |
| 100413-4 |
http://loinc.org | Fennel Fresh IgG Ab [Units/volume] in Serum |
| 100414-2 |
http://loinc.org | Gourd IgG Ab [Units/volume] in Serum |
| 100415-9 |
http://loinc.org | Kale IgG Ab [Units/volume] in Serum |
| 100416-7 |
http://loinc.org | Savoy cabbage IgG Ab [Units/volume] in Serum |
| 100417-5 |
http://loinc.org | Vitis sp leaf IgG Ab [Units/volume] in Serum |
| 100418-3 |
http://loinc.org | Liquorice IgG Ab [Units/volume] in Serum |
| 100419-1 |
http://loinc.org | Snow pea IgG Ab [Units/volume] in Serum |
| 10042-0 |
http://loinc.org | S wave amplitude in lead V3 |
| 100420-9 |
http://loinc.org | Fava bean IgG Ab [Units/volume] in Serum |
| 100421-7 |
http://loinc.org | Chick Pea IgG Ab [Units/volume] in Serum |
| 100422-5 |
http://loinc.org | Chicory IgG Ab [Units/volume] in Serum |
| 100423-3 |
http://loinc.org | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum |
| 100424-1 |
http://loinc.org | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma |
| 100425-8 |
http://loinc.org | DiHydro T-Mas [Mass/volume] in Serum or Plasma |
| 100426-6 |
http://loinc.org | Squalene [Mass/volume] in Serum or Plasma |
| 100427-4 |
http://loinc.org | Stigmasterol [Mass/volume] in Serum or Plasma |
| 100428-2 |
http://loinc.org | Carnitine free and total and acylcarnitine panel - Urine |
| 100429-0 |
http://loinc.org | LRBA deficiency panel - Blood |
| 100430-8 |
http://loinc.org | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) |
| 100431-6 |
http://loinc.org | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |
| 100432-4 |
http://loinc.org | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) |
| 100433-2 |
http://loinc.org | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |
| 100434-0 |
http://loinc.org | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection |
| 100435-7 |
http://loinc.org | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay |
| 100436-5 |
http://loinc.org | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay |
| 100437-3 |
http://loinc.org | Norsufentanil [Mass/volume] in Urine by Confirmatory method |
| 10043-8 |
http://loinc.org | S wave amplitude in lead V4 |
| 100438-1 |
http://loinc.org | Adolescent medicine Outpatient Progress note |
| 100439-9 |
http://loinc.org | Allergy and Immunology Outpatient Progress note |
| 100440-7 |
http://loinc.org | Allergy Outpatient Progress note |
| 100441-5 |
http://loinc.org | Attending Outpatient Progress note |
| 100442-3 |
http://loinc.org | Audiology Outpatient Progress note |
| 100443-1 |
http://loinc.org | Bariatric surgery Outpatient Progress note |
| 100444-9 |
http://loinc.org | Blood banking and transfusion medicine Outpatient Progress note |
| 100445-6 |
http://loinc.org | Bone Marrow Transplant Outpatient Progress note |
| 10044-6 |
http://loinc.org | S wave amplitude in lead V5 |
| 100446-4 |
http://loinc.org | Breastfeeding Outpatient Progress note |
| 100447-2 |
http://loinc.org | Burn management Outpatient Progress note |
| 100448-0 |
http://loinc.org | Cardiac surgery Outpatient Progress note |
| 100449-8 |
http://loinc.org | Cardiopulmonary Outpatient Progress note |
| 100450-6 |
http://loinc.org | Child and adolescent psychiatry Outpatient Progress note |
| 100451-4 |
http://loinc.org | Chiropractic medicine Outpatient Progress note |
| 100452-2 |
http://loinc.org | Clinical cardiac electrophysiology Outpatient Progress note |
| 10045-3 |
http://loinc.org | S wave amplitude in lead V6 |
| 100453-0 |
http://loinc.org | Clinical genetics Outpatient Progress note |
| 100454-8 |
http://loinc.org | Clinical neurophysiology Outpatient Progress note |
| 100455-5 |
http://loinc.org | Clinical pathology Outpatient Progress note |
| 100456-3 |
http://loinc.org | Colon and rectal surgery Outpatient Progress note |
| 100457-1 |
http://loinc.org | Consultant Outpatient Progress note |
| 100458-9 |
http://loinc.org | Outpatient COVID-19 Intubation Progress note |
| 100459-7 |
http://loinc.org | Outpatient COVID-19 Progress note |
| 100460-5 |
http://loinc.org | Dermatology Outpatient Progress note |
| 10046-1 |
http://loinc.org | S wave duration in lead AVF |
| 100461-3 |
http://loinc.org | Developmental-behavioral pediatrics Outpatient Progress note |
| 100462-1 |
http://loinc.org | Dialysis and Therapeutic apheresis Outpatient Progress note |
| 100463-9 |
http://loinc.org | Eating disorders Outpatient Progress note |
| 100464-7 |
http://loinc.org | Endocrinology Outpatient Progress note |
| 100465-4 |
http://loinc.org | Family medicine Outpatient Progress note |
| 100466-2 |
http://loinc.org | Gastroenterology Outpatient Progress note |
| 100467-0 |
http://loinc.org | Geriatric medicine Outpatient Progress note |
| 100468-8 |
http://loinc.org | Gynecologic oncology Outpatient Progress note |
| 100469-6 |
http://loinc.org | Gynecology Outpatient Progress note |
| 100470-4 |
http://loinc.org | Healthcare navigator Outpatient Progress note |
| 100471-2 |
http://loinc.org | Heart failure Outpatient Progress note |
| 100472-0 |
http://loinc.org | Heart failure+Transplant cardiology Outpatient Progress note |
| 100473-8 |
http://loinc.org | Hematology Outpatient Progress note |
| 100474-6 |
http://loinc.org | Hematology+Medical oncology Outpatient Progress note |
| 100475-3 |
http://loinc.org | Hepatology Outpatient Progress note |
| 100476-1 |
http://loinc.org | Immunology Outpatient Progress note |
| 100477-9 |
http://loinc.org | Infectious disease Outpatient Progress note |
| 100478-7 |
http://loinc.org | Internal medicine Outpatient Progress note |
| 10047-9 |
http://loinc.org | S wave duration in lead AVL |
| 100479-5 |
http://loinc.org | Interventional cardiology Outpatient Progress note |
| 100480-3 |
http://loinc.org | Interventional radiology Outpatient Progress note |
| 100481-1 |
http://loinc.org | Outpatient Mechanical circulatory support Progress note |
| 100482-9 |
http://loinc.org | Medical Aid in Dying Outpatient Progress note |
| 100483-7 |
http://loinc.org | Mental health Outpatient Progress note |
| 100484-5 |
http://loinc.org | Multi-specialty program Outpatient Progress note |
| 100485-2 |
http://loinc.org | Neonatal perinatal medicine Outpatient Progress note |
| 100486-0 |
http://loinc.org | Nephrology Outpatient Progress note |
| 10048-7 |
http://loinc.org | S wave duration in lead AVR |
| 100487-8 |
http://loinc.org | Neurological surgery Outpatient Progress note |
| 100488-6 |
http://loinc.org | Neurology Outpatient Progress note |
| 100489-4 |
http://loinc.org | Neurology with special qualifications in child neurology Outpatient Progress note |
| 100490-2 |
http://loinc.org | Nurse practitioner Outpatient Progress note |
| 100491-0 |
http://loinc.org | Nurse Outpatient Progress note |
| 100492-8 |
http://loinc.org | Nutrition and dietetics Outpatient Progress note |
| 100493-6 |
http://loinc.org | Obstetrics and Gynecology Outpatient Progress note |
| 100494-4 |
http://loinc.org | Obstetrics Outpatient Progress note |
| 10049-5 |
http://loinc.org | S wave duration in lead I |
| 100495-1 |
http://loinc.org | Occupational therapy Outpatient Progress note |
| 100496-9 |
http://loinc.org | Oncology Outpatient Progress note |
| 100497-7 |
http://loinc.org | Ophthalmology Outpatient Progress note |
| 100498-5 |
http://loinc.org | Optometry Outpatient Progress note |
| 100499-3 |
http://loinc.org | Oral and Maxillofacial Surgery Outpatient Progress note |
| 100500-8 |
http://loinc.org | Orthopaedic surgery Outpatient Progress note |
| 100501-6 |
http://loinc.org | Orthotics prosthetics Outpatient Progress note |
| 100502-4 |
http://loinc.org | Otolaryngology Outpatient Progress note |
| 10050-3 |
http://loinc.org | S wave duration in lead II |
| 100503-2 |
http://loinc.org | Pain medicine Outpatient Progress note |
| 100504-0 |
http://loinc.org | Palliative care Outpatient Progress note |
| 100505-7 |
http://loinc.org | Pediatric cardiology Outpatient Progress note |
| 100506-5 |
http://loinc.org | Pediatric dermatology Outpatient Progress note |
| 100507-3 |
http://loinc.org | Pediatric endocrinology Outpatient Progress note |
| 100508-1 |
http://loinc.org | Pediatric gastroenterology Outpatient Progress note |
| 100509-9 |
http://loinc.org | Pediatric hematology-oncology Outpatient Progress note |
| 100510-7 |
http://loinc.org | Pediatric infectious diseases Outpatient Progress note |
| 10051-1 |
http://loinc.org | S wave duration in lead III |
| 100511-5 |
http://loinc.org | Pediatric otolaryngology Outpatient Progress note |
| 100512-3 |
http://loinc.org | Pediatric pulmonology Outpatient Progress note |
| 100513-1 |
http://loinc.org | Pediatric rheumatology Outpatient Progress note |
| 100514-9 |
http://loinc.org | Pediatric surgery Outpatient Progress note |
| 100515-6 |
http://loinc.org | Pediatric transplant hepatology Outpatient Progress note |
| 100516-4 |
http://loinc.org | Pediatric urology Outpatient Progress note |
| 100517-2 |
http://loinc.org | Pharmacogenomics Outpatient Progress note |
| 100518-0 |
http://loinc.org | Physical medicine and rehab Outpatient Progress note |
| 100519-8 |
http://loinc.org | Physical therapy Outpatient Progress note |
| 100520-6 |
http://loinc.org | Plastic surgery Outpatient Progress note |
| 100521-4 |
http://loinc.org | Podiatry Outpatient Progress note |
| 100522-2 |
http://loinc.org | Psychiatry Hospital Progress note |
| 100523-0 |
http://loinc.org | Psychology Outpatient Progress note |
| 100524-8 |
http://loinc.org | Pulmonary Outpatient Progress note |
| 100525-5 |
http://loinc.org | Radiation oncology Outpatient Progress note |
| 100526-3 |
http://loinc.org | Radiology Outpatient Progress note |
| 100527-1 |
http://loinc.org | Recreational therapy Outpatient Progress note |
| 100528-9 |
http://loinc.org | Reproductive endocrinology and infertility Outpatient Progress note |
| 10052-9 |
http://loinc.org | S wave duration in lead V1 |
| 100529-7 |
http://loinc.org | Research Outpatient Progress note |
| 100530-5 |
http://loinc.org | Rheumatology Outpatient Progress note |
| 100531-3 |
http://loinc.org | Sleep medicine Outpatient Progress note |
| 100532-1 |
http://loinc.org | Social worker Outpatient Progress note |
| 100533-9 |
http://loinc.org | Solid Organ Transplant Outpatient Progress note |
| 100534-7 |
http://loinc.org | Speech-language pathology Outpatient Progress note |
| 100535-4 |
http://loinc.org | Spinal surgery Outpatient Progress note |
| 100536-2 |
http://loinc.org | Sports medicine Outpatient Progress note |
| 10053-7 |
http://loinc.org | S wave duration in lead V2 |
| 100537-0 |
http://loinc.org | Surgery of the hand Outpatient Progress note |
| 100538-8 |
http://loinc.org | Telehealth+Outpatient Progress note |
| 100539-6 |
http://loinc.org | Thromboembolism Outpatient Progress note |
| 100540-4 |
http://loinc.org | Transplant surgery Outpatient Progress note |
| 100541-2 |
http://loinc.org | Trauma Outpatient Progress note |
| 100542-0 |
http://loinc.org | Urology Outpatient Progress note |
| 100543-8 |
http://loinc.org | Vascular neurology Outpatient Progress note |
| 100544-6 |
http://loinc.org | Vascular surgery Outpatient Progress note |
| 10054-5 |
http://loinc.org | S wave duration in lead V3 |
| 100545-3 |
http://loinc.org | Wound care management Outpatient Progress note |
| 100546-1 |
http://loinc.org | Wound, Ostomy, and Continence Care Outpatient Progress note |
| 100547-9 |
http://loinc.org | Adolescent medicine Hospital Progress note |
| 100548-7 |
http://loinc.org | Allergy and Immunology Hospital Progress note |
| 100549-5 |
http://loinc.org | Allergy Hospital Progress note |
| 100550-3 |
http://loinc.org | Attending Hospital Progress note |
| 100551-1 |
http://loinc.org | Audiology Hospital Progress note |
| 10055-2 |
http://loinc.org | S wave duration in lead V4 |
| 100552-9 |
http://loinc.org | Bariatric surgery Hospital Progress note |
| 100553-7 |
http://loinc.org | Blood banking and transfusion medicine Hospital Progress note |
| 100554-5 |
http://loinc.org | Bone Marrow Transplant Hospital Progress note |
| 100555-2 |
http://loinc.org | Breastfeeding Hospital Progress note |
| 100556-0 |
http://loinc.org | Burn management Hospital Progress note |
| 100557-8 |
http://loinc.org | Cardiac surgery Hospital Progress note |
| 100558-6 |
http://loinc.org | Cardiopulmonary Hospital Progress note |
| 100559-4 |
http://loinc.org | Child and adolescent psychiatry Hospital Progress note |
| 10056-0 |
http://loinc.org | S wave duration in lead V5 |
| 100560-2 |
http://loinc.org | Clinical cardiac electrophysiology Hospital Progress note |
| 100561-0 |
http://loinc.org | Clinical genetics Hospital Progress note |
| 100562-8 |
http://loinc.org | Clinical neurophysiology Hospital Progress note |
| 100563-6 |
http://loinc.org | Clinical pathology Hospital Progress note |
| 100564-4 |
http://loinc.org | Colon and rectal surgery Hospital Progress note |
| 100565-1 |
http://loinc.org | Consultant Hospital Progress note |
| 100566-9 |
http://loinc.org | Dentistry Hospital Progress note |
| 100567-7 |
http://loinc.org | Dermatology Hospital Progress note |
| 100568-5 |
http://loinc.org | Developmental-behavioral pediatrics Hospital Progress note |
| 100569-3 |
http://loinc.org | Dialysis and Therapeutic apheresis Hospital Progress note |
| 100570-1 |
http://loinc.org | Eating disorders Hospital Progress note |
| 100571-9 |
http://loinc.org | Endocrinology Hospital Progress note |
| 100572-7 |
http://loinc.org | Family medicine Hospital Progress note |
| 100573-5 |
http://loinc.org | Gastroenterology Hospital Progress note |
| 100574-3 |
http://loinc.org | General medicine Hospital Progress note |
| 100575-0 |
http://loinc.org | Geriatric medicine Hospital Progress note |
| 100576-8 |
http://loinc.org | Gynecologic oncology Hospital Progress note |
| 100577-6 |
http://loinc.org | Gynecology Hospital Progress note |
| 10057-8 |
http://loinc.org | S wave duration in lead V6 |
| 100578-4 |
http://loinc.org | Healthcare navigator Hospital Progress note |
| 100579-2 |
http://loinc.org | Heart failure Hospital Progress note |
| 1005-8 |
http://loinc.org | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |
| 100580-0 |
http://loinc.org | Heart failure+Transplant cardiology Hospital Progress note |
| 100581-8 |
http://loinc.org | Hematology Hospital Progress note |
| 100582-6 |
http://loinc.org | Hematology+Medical oncology Hospital Progress note |
| 100583-4 |
http://loinc.org | Hepatology Hospital Progress note |
| 100584-2 |
http://loinc.org | Immunology Hospital Progress note |
| 100585-9 |
http://loinc.org | Infectious disease Hospital Progress note |
| 10058-6 |
http://loinc.org | S' wave amplitude in lead AVF |
| 100586-7 |
http://loinc.org | Internal medicine Hospital Progress note |
| 100587-5 |
http://loinc.org | Interventional cardiology Hospital Progress note |
| 100588-3 |
http://loinc.org | Interventional radiology Hospital Progress note |
| 100589-1 |
http://loinc.org | Hospital Mechanical circulatory support Progress note |
| 100590-9 |
http://loinc.org | Medical Aid in Dying Hospital Progress note |
| 100591-7 |
http://loinc.org | Mental health Hospital Progress note |
| 100592-5 |
http://loinc.org | Multi-specialty program Hospital Progress note |
| 100593-3 |
http://loinc.org | Neonatal perinatal medicine Hospital Progress note |
| 10059-4 |
http://loinc.org | S' wave amplitude in lead AVL |
| 100594-1 |
http://loinc.org | Nephrology Hospital Progress note |
| 100595-8 |
http://loinc.org | Neurological surgery Hospital Progress note |
| 100596-6 |
http://loinc.org | Neurology Hospital Progress note |
| 100597-4 |
http://loinc.org | Neurology with special qualifications in child neurology Hospital Progress note |
| 100598-2 |
http://loinc.org | Nurse practitioner Hospital Progress note |
| 100599-0 |
http://loinc.org | Nurse Hospital Progress note |
| 100600-6 |
http://loinc.org | Nutrition and dietetics Hospital Progress note |
| 100601-4 |
http://loinc.org | Obstetrics and Gynecology Hospital Progress note |
| 10060-2 |
http://loinc.org | S' wave amplitude in lead AVR |
| 100602-2 |
http://loinc.org | Obstetrics Hospital Progress note |
| 100603-0 |
http://loinc.org | Occupational therapy Hospital Progress note |
| 100604-8 |
http://loinc.org | Oncology Hospital Progress note |
| 100605-5 |
http://loinc.org | Ophthalmology Hospital Progress note |
| 100606-3 |
http://loinc.org | Oral and Maxillofacial Surgery Hospital Progress note |
| 100607-1 |
http://loinc.org | Orthopaedic surgery Hospital Progress note |
| 100608-9 |
http://loinc.org | Orthotics prosthetics Hospital Progress note |
| 100609-7 |
http://loinc.org | Otolaryngology Hospital Progress note |
| 10061-0 |
http://loinc.org | S' wave amplitude in lead I |
| 100610-5 |
http://loinc.org | Pain medicine Hospital Progress note |
| 100611-3 |
http://loinc.org | Palliative care Hospital Progress note |
| 100612-1 |
http://loinc.org | Pastoral care Hospital Progress note |
| 100613-9 |
http://loinc.org | Pediatric cardiology Hospital Progress note |
| 100614-7 |
http://loinc.org | Pediatric dermatology Hospital Progress note |
| 100615-4 |
http://loinc.org | Pediatric endocrinology Hospital Progress note |
| 100616-2 |
http://loinc.org | Pediatric gastroenterology Hospital Progress note |
| 100617-0 |
http://loinc.org | Pediatric hematology-oncology Hospital Progress note |
| 100618-8 |
http://loinc.org | Pediatric infectious diseases Hospital Progress note |
| 100619-6 |
http://loinc.org | Pediatric otolaryngology Hospital Progress note |
| 100620-4 |
http://loinc.org | Pediatric pulmonology Hospital Progress note |
| 100621-2 |
http://loinc.org | Pediatric rheumatology Hospital Progress note |
| 100622-0 |
http://loinc.org | Pediatric surgery Hospital Progress note |
| 100623-8 |
http://loinc.org | Pediatric transplant hepatology Hospital Progress note |
| 100624-6 |
http://loinc.org | Pharmacogenomics Hospital Progress note |
| 100625-3 |
http://loinc.org | Pharmacology Hospital Progress note |
| 100626-1 |
http://loinc.org | Physical medicine and rehab Hospital Progress note |
| 100627-9 |
http://loinc.org | Physical therapy Hospital Progress note |
| 10062-8 |
http://loinc.org | S' wave amplitude in lead II |
| 100628-7 |
http://loinc.org | Plastic surgery Hospital Progress note |
| 100629-5 |
http://loinc.org | Podiatry Hospital Progress note |
| 100630-3 |
http://loinc.org | Psychology Hospital Progress note |
| 100631-1 |
http://loinc.org | Radiation oncology Hospital Progress note |
| 100632-9 |
http://loinc.org | Radiology Hospital Progress note |
| 100633-7 |
http://loinc.org | Rapid response team Hospital Progress note |
| 100634-5 |
http://loinc.org | Recreational therapy Hospital Progress note |
| 100635-2 |
http://loinc.org | Reproductive endocrinology and infertility Hospital Progress note |
| 10063-6 |
http://loinc.org | S' wave amplitude in lead III |
| 100636-0 |
http://loinc.org | Research Hospital Progress note |
| 100637-8 |
http://loinc.org | Rheumatology Hospital Progress note |
| 100638-6 |
http://loinc.org | Sleep medicine Hospital Progress note |
| 100639-4 |
http://loinc.org | Social worker Hospital Progress note |
| 100640-2 |
http://loinc.org | Solid Organ Transplant Hospital Progress note |
| 100641-0 |
http://loinc.org | Speech-language pathology Hospital Progress note |
| 100642-8 |
http://loinc.org | Spinal surgery Hospital Progress note |
| 100643-6 |
http://loinc.org | Surgery of the hand Hospital Progress note |
| 10064-4 |
http://loinc.org | S' wave amplitude in lead V1 |
| 100644-4 |
http://loinc.org | Thromboembolism Hospital Progress note |
| 100645-1 |
http://loinc.org | Trauma Hospital Progress note |
| 100646-9 |
http://loinc.org | Urology Hospital Progress note |
| 100647-7 |
http://loinc.org | Vascular neurology Hospital Progress note |
| 100648-5 |
http://loinc.org | Vascular surgery Hospital Progress note |
| 100649-3 |
http://loinc.org | Wound care management Hospital Progress note |
| 100650-1 |
http://loinc.org | Wound, Ostomy, and Continence Care Hospital Progress note |
| 10065-1 |
http://loinc.org | S' wave amplitude in lead V2 |
| 100651-9 |
http://loinc.org | Hospital COVID-19 Intubation Progress note |
| 100652-7 |
http://loinc.org | Pure tone bone conduction threshold audiometry panel |
| 100653-5 |
http://loinc.org | Pure tone air conduction threshold audiometry panel |
| 100654-3 |
http://loinc.org | Pyruvate kinase M2 [Presence] in Stool |
| 100655-0 |
http://loinc.org | XR Sella turcica Lateral |
| 100656-8 |
http://loinc.org | Maternal and fetal medicine Outpatient Progress note |
| 100657-6 |
http://loinc.org | Maternal and fetal medicine Telephone encounter+Hospital Progress note |
| 100658-4 |
http://loinc.org | Hospital COVID-19 Progress note |
| 100659-2 |
http://loinc.org | Maternal and fetal medicine Hospital Progress note |
| 1006-6 |
http://loinc.org | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |
| 100660-0 |
http://loinc.org | Maternal and fetal medicine Telephone encounter+Outpatient Progress note |
| 100661-8 |
http://loinc.org | Psychiatry Outpatient Progress note |
| 100662-6 |
http://loinc.org | Cortisol free and total panel - Serum or Plasma |
| 100663-4 |
http://loinc.org | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method |
| 100664-2 |
http://loinc.org | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method |
| 100665-9 |
http://loinc.org | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method |
| 100666-7 |
http://loinc.org | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method |
| 100667-5 |
http://loinc.org | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method |
| 100668-3 |
http://loinc.org | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method |
| 10066-9 |
http://loinc.org | S' wave amplitude in lead V3 |
| 100669-1 |
http://loinc.org | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method |
| 100670-9 |
http://loinc.org | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus |
| 100671-7 |
http://loinc.org | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection |
| 100672-5 |
http://loinc.org | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection |
| 100673-3 |
http://loinc.org | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection |
| 100674-1 |
http://loinc.org | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100675-8 |
http://loinc.org | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
| 100676-6 |
http://loinc.org | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection |
| 10067-7 |
http://loinc.org | S' wave amplitude in lead V4 |
| 100677-4 |
http://loinc.org | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 100678-2 |
http://loinc.org | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100679-0 |
http://loinc.org | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 100680-8 |
http://loinc.org | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100681-6 |
http://loinc.org | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 100682-4 |
http://loinc.org | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100683-2 |
http://loinc.org | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 100684-0 |
http://loinc.org | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 10068-5 |
http://loinc.org | S' wave amplitude in lead V5 |
| 100685-7 |
http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 100686-5 |
http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 100687-3 |
http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |
| 100688-1 |
http://loinc.org | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100689-9 |
http://loinc.org | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection |
| 100690-7 |
http://loinc.org | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection |
| 100691-5 |
http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100692-3 |
http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 10069-3 |
http://loinc.org | S' wave amplitude in lead V6 |
| 100693-1 |
http://loinc.org | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection |
| 100694-9 |
http://loinc.org | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method |
| 100695-6 |
http://loinc.org | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative |
| 100696-4 |
http://loinc.org | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal |
| 100697-2 |
http://loinc.org | Interventional radiology Outpatient Note |
| 100698-0 |
http://loinc.org | Social Determinants of Health screening report Document |
| 100699-8 |
http://loinc.org | Rifabutin+Ethambutol [Susceptibility] |
| 100700-4 |
http://loinc.org | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection |
| 10070-1 |
http://loinc.org | S' wave duration in lead AVF |
| 100701-2 |
http://loinc.org | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection |
| 100702-0 |
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection |
| 100703-8 |
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection |
| 100704-6 |
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection |
| 100705-3 |
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection |
| 100706-1 |
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection |
| 100707-9 |
http://loinc.org | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count |
| 100708-7 |
http://loinc.org | Plasma cells/100 leukocytes in Synovial fluid |
| 100709-5 |
http://loinc.org | Hepatocellular carcinoma risk [Score] by GAAD |
| 100710-3 |
http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection |
| 100711-1 |
http://loinc.org | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay |
| 100712-9 |
http://loinc.org | Brexpiprazole [Mass/volume] in Serum or Plasma |
| 100713-7 |
http://loinc.org | Cariprazine [Mass/volume] in Serum or Plasma |
| 100714-5 |
http://loinc.org | Guanfacine [Mass/volume] in Serum or Plasma |
| 100715-2 |
http://loinc.org | Prothipendyl [Mass/volume] in Serum or Plasma |
| 100716-0 |
http://loinc.org | Prostate specific Ag [Mass/volume] in DBS |
| 100717-8 |
http://loinc.org | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method |
| 100718-6 |
http://loinc.org | Undersea and hyperbaric medicine Discharge summary |
| 10071-9 |
http://loinc.org | S' wave duration in lead AVL |
| 100719-4 |
http://loinc.org | Surgical oncology Discharge summary |
| 100720-2 |
http://loinc.org | Reproductive endocrinology and infertility Discharge summary |
| 100721-0 |
http://loinc.org | Community health care Discharge summary |
| 100722-8 |
http://loinc.org | Integrative medicine Discharge summary |
| 100723-6 |
http://loinc.org | Sports medicine Discharge summary |
| 100724-4 |
http://loinc.org | Diabetology Discharge summary |
| 100725-1 |
http://loinc.org | Optometry Discharge summary |
| 100726-9 |
http://loinc.org | Podiatry Discharge summary |
| 10072-7 |
http://loinc.org | S' wave duration in lead AVR |
| 100727-7 |
http://loinc.org | Chiropractic medicine Discharge summary |
| 100728-5 |
http://loinc.org | Cardiac surgery Discharge summary |
| 100729-3 |
http://loinc.org | Breastfeeding Discharge summary |
| 100730-1 |
http://loinc.org | Transplant surgery Discharge summary |
| 100731-9 |
http://loinc.org | Urgent care center Discharge summary |
| 100732-7 |
http://loinc.org | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum |
| 100733-5 |
http://loinc.org | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) |
| 100734-3 |
http://loinc.org | traMADol and Metabolites Panel - Urine by Confirmatory method |
| 10073-5 |
http://loinc.org | S' wave duration in lead I |
| 100735-0 |
http://loinc.org | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes |
| 100736-8 |
http://loinc.org | Acylcarnitine Analysis Post Mortem in Specimen Document |
| 100737-6 |
http://loinc.org | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma |
| 100738-4 |
http://loinc.org | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma |
| 100739-2 |
http://loinc.org | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma |
| 1007-4 |
http://loinc.org | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells |
| 100740-0 |
http://loinc.org | Amylase.macromolecular [Presence] in Serum or Plasma |
| 100741-8 |
http://loinc.org | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma |
| 100742-6 |
http://loinc.org | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma |
| 10074-3 |
http://loinc.org | S' wave duration in lead II |
| 100743-4 |
http://loinc.org | Lipase.macromolecular [Presence] in Serum or Plasma |
| 100744-2 |
http://loinc.org | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis |
| 100745-9 |
http://loinc.org | Chloride [Moles/volume] in Mixed venous blood |
| 100746-7 |
http://loinc.org | Glucose [Moles/volume] in Mixed venous blood |
| 100747-5 |
http://loinc.org | Legionella serogroup panel - Specimen |
| 100748-3 |
http://loinc.org | Legionella spp [Presence] in Specimen by NAA with probe detection |
| 100749-1 |
http://loinc.org | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection |
| 10075-0 |
http://loinc.org | S' wave duration in lead III |
| 100750-9 |
http://loinc.org | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection |
| 100751-7 |
http://loinc.org | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma |
| 100752-5 |
http://loinc.org | Exacerbating factors - Reported |
| 100753-3 |
http://loinc.org | Alleviating factors - Reported |
| 100754-1 |
http://loinc.org | Platelet disorders multigene analysis in Blood or Tissue by Sequencing |
| 100755-8 |
http://loinc.org | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing |
| 100756-6 |
http://loinc.org | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing |
| 100757-4 |
http://loinc.org | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing |
| 100758-2 |
http://loinc.org | Estimated lung age by based on clinical data |
| 100759-0 |
http://loinc.org | Inspiratory reserve [Volume] Respiratory system by Spirometry |
| 100760-8 |
http://loinc.org | XR Radius and Ulna - left Single view |
| 100761-6 |
http://loinc.org | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
| 100762-4 |
http://loinc.org | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method |
| 100763-2 |
http://loinc.org | Mycobacterium sp comparative reaction interpretation Narrative |
| 100764-0 |
http://loinc.org | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal |
| 100765-7 |
http://loinc.org | Homocysteine and methylmalonate and methylcitrate panel - DBS |
| 100766-5 |
http://loinc.org | Center for Epidemiologic Studies Depression Scale panel [CES-D] |
| 100767-3 |
http://loinc.org | Bothered by things that are not usually bothersome |
| 10076-8 |
http://loinc.org | S' wave duration in lead V1 |
| 100768-1 |
http://loinc.org | Poor appetite |
| 100769-9 |
http://loinc.org | Unhappy even with help from my family or friends |
| 100770-7 |
http://loinc.org | Feeling just as good as others |
| 100771-5 |
http://loinc.org | Trouble focusing |
| 100772-3 |
http://loinc.org | Feeling depressed |
| 100773-1 |
http://loinc.org | Feeling everything is too much of an effort |
| 100774-9 |
http://loinc.org | Feeling hopeful about the future |
| 100775-6 |
http://loinc.org | Feeling life had been a failure |
| 10077-6 |
http://loinc.org | S' wave duration in lead V2 |
| 100776-4 |
http://loinc.org | Feeling fearful |
| 100777-2 |
http://loinc.org | Restless sleep |
| 100778-0 |
http://loinc.org | Feeling happy |
| 100779-8 |
http://loinc.org | Quieter than usual |
| 100780-6 |
http://loinc.org | Feeling lonely |
| 100781-4 |
http://loinc.org | People were unfriendly |
| 100782-2 |
http://loinc.org | Enjoying life |
| 100783-0 |
http://loinc.org | Crying spells |
| 10078-4 |
http://loinc.org | S' wave duration in lead V3 |
| 100784-8 |
http://loinc.org | Feeling sad |
| 100785-5 |
http://loinc.org | Feeling people dislike me |
| 100786-3 |
http://loinc.org | Lack of energy |
| 100787-1 |
http://loinc.org | Total Score CES-D |
| 100788-9 |
http://loinc.org | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum |
| 100789-7 |
http://loinc.org | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum |
| 100790-5 |
http://loinc.org | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum |
| 100791-3 |
http://loinc.org | Hamster epithelium IgG Ab [Mass/volume] in Serum |
| 10079-2 |
http://loinc.org | S' wave duration in lead V4 |
| 100792-1 |
http://loinc.org | Forsythia IgE Ab [Units/volume] in Serum |
| 100793-9 |
http://loinc.org | Testosterone [Mass/volume] in Body fluid |
| 100794-7 |
http://loinc.org | Follitropin [Units/volume] in Body fluid |
| 100795-4 |
http://loinc.org | S100 calcium binding protein B [Mass/volume] in Body fluid |
| 100796-2 |
http://loinc.org | Thyroglobulin [Mass/volume] in Body fluid |
| 100797-0 |
http://loinc.org | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge |
| 100798-8 |
http://loinc.org | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge |
| 100799-6 |
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge |
| 100-8 |
http://loinc.org | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10080-0 |
http://loinc.org | S' wave duration in lead V5 |
| 100800-2 |
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge |
| 100801-0 |
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge |
| 100802-8 |
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge |
| 100803-6 |
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge |
| 100804-4 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge |
| 100805-1 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge |
| 100806-9 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge |
| 100807-7 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge |
| 100808-5 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge |
| 100809-3 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge |
| 100810-1 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge |
| 100811-9 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge |
| 100812-7 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge |
| 100813-5 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge |
| 100814-3 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge |
| 100815-0 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge |
| 100816-8 |
http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 100817-6 |
http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 10081-8 |
http://loinc.org | S' wave duration in lead V6 |
| 100818-4 |
http://loinc.org | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge |
| 100819-2 |
http://loinc.org | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 1008-2 |
http://loinc.org | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma |
| 100820-0 |
http://loinc.org | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge |
| 100821-8 |
http://loinc.org | National POLST form: portable medical order panel |
| 100822-6 |
http://loinc.org | Cardiopulmonary resuscitation orders |
| 100823-4 |
http://loinc.org | Initial portable medical treatment orders |
| 100824-2 |
http://loinc.org | Additional portable medical orders or instructions |
| 100825-9 |
http://loinc.org | Medically assisted nutrition orders |
| 10082-6 |
http://loinc.org | ST initial amplitude 6 ms in lead AVF |
| 100826-7 |
http://loinc.org | Portable medical order AndOr advance directive review |
| 100827-5 |
http://loinc.org | Portable medical order discussion participants |
| 100828-3 |
http://loinc.org | Portable medical order administrative information |
| 100829-1 |
http://loinc.org | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge |
| 100830-9 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 100831-7 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 100832-5 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 100833-3 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 10083-4 |
http://loinc.org | ST initial amplitude 6 ms in lead AVL |
| 100834-1 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 100835-8 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 100836-6 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 100837-4 |
http://loinc.org | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 100838-2 |
http://loinc.org | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 100839-0 |
http://loinc.org | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma |
| 100840-8 |
http://loinc.org | IgE [Units/volume] in Body fluid |
| 100841-6 |
http://loinc.org | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot |
| 10084-2 |
http://loinc.org | ST initial amplitude 6 ms in lead AVR |
| 100842-4 |
http://loinc.org | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST |
| 100843-2 |
http://loinc.org | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ |
| 100844-0 |
http://loinc.org | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 |
| 100845-7 |
http://loinc.org | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) |
| 100846-5 |
http://loinc.org | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 100847-3 |
http://loinc.org | Gas and ammonia panel - Arterial blood |
| 100848-1 |
http://loinc.org | Cell count and Differential panel - Amniotic fluid by Manual count |
| 100849-9 |
http://loinc.org | Leukocytes [#/volume] in Amniotic fluid by Manual count |
| 100850-7 |
http://loinc.org | Neutrophils [#/volume] in Amniotic fluid by Manual count |
| 100851-5 |
http://loinc.org | Other cells [#/volume] in Amniotic fluid by Manual count |
| 100852-3 |
http://loinc.org | NM Bones Views for metastasis W Sr-89 IV |
| 100853-1 |
http://loinc.org | NM Pericardial space Pericardial effusion |
| 100854-9 |
http://loinc.org | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay |
| 100855-6 |
http://loinc.org | CD3 cells/100 cells in Blood mononuclear cells |
| 100856-4 |
http://loinc.org | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells |
| 100857-2 |
http://loinc.org | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells |
| 100858-0 |
http://loinc.org | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
| 10085-9 |
http://loinc.org | ST initial amplitude 6 ms in lead I |
| 100859-8 |
http://loinc.org | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
| 100860-6 |
http://loinc.org | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
| 100861-4 |
http://loinc.org | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
| 100862-2 |
http://loinc.org | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
| 100863-0 |
http://loinc.org | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
| 100864-8 |
http://loinc.org | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method |
| 100865-5 |
http://loinc.org | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection |
| 100866-3 |
http://loinc.org | Febrile antibody profile in Serum |
| 10086-7 |
http://loinc.org | ST initial amplitude 6 ms in lead II |
| 100867-1 |
http://loinc.org | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay |
| 100868-9 |
http://loinc.org | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method |
| 100869-7 |
http://loinc.org | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method |
| 100870-5 |
http://loinc.org | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method |
| 100871-3 |
http://loinc.org | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method |
| 100872-1 |
http://loinc.org | Bacteria producing polysaccharide from sucrose [Presence] in Isolate |
| 100873-9 |
http://loinc.org | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method |
| 100874-7 |
http://loinc.org | Basidiobolus sp [Presence] in Specimen |
| 10087-5 |
http://loinc.org | ST initial amplitude 6 ms in lead III |
| 100875-4 |
http://loinc.org | Fetal Heart Document limited US |
| 100876-2 |
http://loinc.org | Fetal Heart Document US |
| 100877-0 |
http://loinc.org | US Heart Transesophageal during surgery |
| 100878-8 |
http://loinc.org | Endoscopic ultrasound study Upper GI tract Document |
| 100879-6 |
http://loinc.org | US Guidance for cryoablation of Breast - right |
| 100880-4 |
http://loinc.org | US Guidance for cryoablation of Breast - left |
| 100881-2 |
http://loinc.org | MR Guidance for cryoablation of Bone |
| 100882-0 |
http://loinc.org | MR Peritoneum W contrast percutaneous intraperitoneal |
| 10088-3 |
http://loinc.org | ST initial amplitude 6 ms in lead V1 |
| 100883-8 |
http://loinc.org | MR Guidance for biopsy of Kidney - left |
| 100884-6 |
http://loinc.org | MR Guidance for biopsy of Kidney - right |
| 100885-3 |
http://loinc.org | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection |
| 100886-1 |
http://loinc.org | Orf virus DNA [Presence] in Specimen by NAA with probe detection |
| 100887-9 |
http://loinc.org | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection |
| 100888-7 |
http://loinc.org | Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection |
| 100889-5 |
http://loinc.org | Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection |
| 100890-3 |
http://loinc.org | Poxvirus DNA panel |
| 10089-1 |
http://loinc.org | ST initial amplitude 6 ms in lead V2 |
| 100891-1 |
http://loinc.org | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 100892-9 |
http://loinc.org | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 100893-7 |
http://loinc.org | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma |
| 100894-5 |
http://loinc.org | Recommended screening frequency Narrative |
| 100895-2 |
http://loinc.org | Rickettsia conorii IgG and IgM [Interpretation] in Serum |
| 100896-0 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge |
| 100897-8 |
http://loinc.org | Staphylococcus aureus [Presence] in Specimen by Organism specific culture |
| 100898-6 |
http://loinc.org | Lipid panel - Serum or Plasma |
| 100899-4 |
http://loinc.org | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture |
Additional Language Displays
| Code | Deutsch (Österreich) (German (Austria), de) | Deutsch (Deutschland) (German (Germany), de) | English (United States) (English (United States), en) | Spanish (Argentina) (es) | Spanish (es) | French (France) (fr) | Nederlands (Nederland) (Dutch (Netherlands), nl) | Portuguese (Brazil) (pt) |
| 100000-9 | Health Info Pioneer+Father of LOINC | |||||||
| 100001-7 | Health Info Pioneer+Cofound LOINC | |||||||
| 100002-5 | Specimen care is maintained | |||||||
| 100003-3 | Team communication is maintained throughout care | |||||||
| 100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure | |||||||
| 100005-8 | Demonstrates knowledge of nutritional management related to the procedure | |||||||
| 100006-6 | Demonstrates knowledge of medication management | |||||||
| 100007-4 | Demonstrates knowledge of pain management | |||||||
| 10000-8 | R wave dur L-AVR | duración de la onda R.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-AVR | ||||
| 100008-2 | Demonstrates knowledge of wound management | |||||||
| 100009-0 | Demonstrates knowledge of the procedure and expected results | |||||||
| 100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation | |||||||
| 100011-6 | No injury related to an electrical source | |||||||
| 100012-4 | Participates in decisions affecting the patient's plan of care | |||||||
| 100013-2 | Participates in the discharge process | |||||||
| 100014-0 | Psychosocial health is maintained at or improved from baseline | |||||||
| 100015-7 | No injury related to positioning due to care or procedure | |||||||
| 10001-6 | R wave dur L-I | duración de la onda R.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-I | ||||
| 100016-5 | No injury related to a laser source | |||||||
| 100017-3 | Perioperative nursing data set outcomes panel [PNDS] | |||||||
| 100018-1 | Hospice care Note | Verslag [bevinding] in {instelling} d.m.v. hospicezorg (document) | ||||||
| 100019-9 | ALK gene targeted mutation analysis, Blood or tissue specimen | ALK gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | ALK-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100020-7 | GNA11 gene targeted mutation analysis, Blood or tissue specimen | GNA11 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | GNA11-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100021-5 | GNAQ gene targeted mutation analysis, Blood or tissue specimen | GNAQ gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | GNAQ-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100022-3 | IDH1 gene targeted mutation analysis, Blood or tissue specimen | IDH1 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | IDH1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100023-1 | IDH2 gene targeted mutation analysis, Blood or tissue specimen | IDH2 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | IDH2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 10002-4 | R wave dur L-II | duración de la onda R.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-II | ||||
| 100024-9 | SETBP1 gene targeted mutation analysis, Blood or tissue specimen | SETBP1 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | SETBP1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100025-6 | SRSF2 gene targeted mutation analysis, Blood or tissue specimen | SRSF2 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | SRSF2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100026-4 | MET gene targeted mutation analysis, Blood or tissue specimen | MET gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | MET-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100027-2 | SMAD4 gene targeted mutation analysis, Blood or tissue specimen | SMAD4 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | SMAD4-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100028-0 | FBXW7 gene targeted mutation analysis, Blood or tissue specimen | FBXW7 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | FBXW7-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100029-8 | Cancer related multigene analysis (cfDNA) | Analyse multigénique en relation avec le cancer [Recherche] Plasma avec ADN libre circulant ; Document ; Biologie moléculaire | Kankergerelateerde multigen-analyse [bevinding] in plasma.celvrij DNA d.m.v. moleculair genetisch onderzoek (document) | |||||
| 100030-6 | Axis I: Temporal aspects score [Mainz Pain Staging System] | |||||||
| 100031-4 | Axis II: Spatial aspects score [Mainz Pain Staging System] | |||||||
| 10003-2 | R wave dur L-III | duración de la onda R.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-III | ||||
| 100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] | |||||||
| 100033-0 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | |||||||
| 100034-8 | Provider of AED | |||||||
| 100035-5 | Exam finding location Chest | |||||||
| 100036-3 | Exam finding location Lung | |||||||
| 100037-1 | Patient contact disposition EMS unit | |||||||
| 100038-9 | Patient eval disposition EMS unit | |||||||
| 100039-7 | Crew disposition EMS unit | |||||||
| 10004-0 | R wave dur L-V1 | duración de la onda R.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V1 | ||||
| 100040-5 | Pt transport disposition EMS unit | |||||||
| 100041-3 | Aminoglycosid-Empfindlichkeit | Aminoglycosid [Empfindlichkeit] | Susceptibility to Aminoglycoside | Aminoglycoside [Sensibilité] Isolat ; Alphanumérique | ||||
| 100042-1 | Atovaquon-Empfindlichkeit | Susceptibility to Atovaquone | Atovaquone [Sensibilité] Isolat ; Alphanumérique | Atovaquone [gevoeligheid] in isolaat | ||||
| 100043-9 | Azithromycin/Ethambutol-Empfindlichkeit | Azithromycin+Ethambutol [Empfindlichkeit] | Susceptibility to Azithromycin+Ethambutol | Azithromycine+éthambutol [Sensibilité] Isolat ; Alphanumérique | Azitromycine + ethambutol [gevoeligheid] in isolaat | |||
| 100044-7 | Cefcapene-Empfindlichkeit | Cefcapen [Empfindlichkeit] | Susceptibility to Cefcapene | Cefcapene [Sensibilité] Isolat ; Alphanumérique | Cefcapeen [gevoeligheid] in isolaat | |||
| 100045-4 | Cefozopran-Empfindlichkeit | Susceptibility to Cefozopran | Céfozopran [Sensibilité] Isolat ; Alphanumérique | Cefozopran [gevoeligheid] in isolaat | ||||
| 100046-2 | Cefquinom-Empfindlichkeit | Susceptibility to Cefquinome | Cefquinome [Sensibilité] Isolat ; Alphanumérique | Cefquinome [gevoeligheid] in isolaat | ||||
| 100047-0 | Cefteram-Empfindlichkeit | Susceptibility to Cefteram | Cefteram [Sensibilité] Isolat ; Alphanumérique | Cefteram [gevoeligheid] in isolaat | ||||
| 100048-8 | Clarithromycin/Ethambutol-Empfindlichkeit | Clarithromycin+Ethambutol [Empfindlichkeit] | Susceptibility to Clarithromycin+Ethambutol | Clarithromycine+éthambutol [Sensibilité] Isolat ; Alphanumérique | Clarithromycine + ethambutol [gevoeligheid] in isolaat | |||
| 100049-6 | Eravacycline-Empfindlichkeit | Eravacyclin [Empfindlichkeit] | Susceptibility to Eravacycline | Éravacycline [Sensibilité] Isolat ; Alphanumérique | Eravacycline [gevoeligheid] in isolaat | |||
| 100050-4 | Erythromycin/Ethambutol-Empfindlichkeit | Erythromycin+Ethambutol [Empfindlichkeit] | Susceptibility to Erythromycin+Ethambutol | Érythromycine+éthambutol [Sensibilité] Isolat ; Alphanumérique | Erytromycine + ethambutol [gevoeligheid] in isolaat | |||
| 100051-2 | Ethambutol/rifAMPin-Empfindlichkeit | Ethambutol+Rifampicin [Empfindlichkeit] | Susceptibility to Ethambutol+rifAMPin | Éthambutol+rifampicine [Sensibilité] Isolat ; Alphanumérique | Ethambutol + rifampicine [gevoeligheid] in isolaat | |||
| 100052-0 | Flomoxef-Empfindlichkeit | Flomoxef [Empfindlichkeit] | Susceptibility to Flomoxef | Flomoxef [Sensibilité] Isolat ; Alphanumérique | Flomoxef [gevoeligheid] in isolaat | |||
| 100053-8 | Fluoroquinolon-Empfindlichkeit | Fluorchinolon [Empfindlichkeit] | Susceptibility to Fluoroquinolone | Fluoroquinolone [Sensibilité] Isolat ; Alphanumérique | Fluorchinolon [gevoeligheid] in isolaat | |||
| 100054-6 | Gamithromycin-Empfindlichkeit | Susceptibility to Gamithromycin | Gamithromycine [Sensibilité] Isolat ; Alphanumérique | |||||
| 100055-3 | Optochin-Empfindlichkeit | Optochin [Empfindlichkeit] | Susceptibility to Optochin | Optochine [Sensibilité] Isolat ; Alphanumérique | Optochine [gevoeligheid] in isolaat | |||
| 100056-1 | Panipenem-Empfindlichkeit | Panipenem [Empfindlichkeit] | Susceptibility to Panipenem | Panipénème [Sensibilité] Isolat ; Alphanumérique | Panipenem [gevoeligheid] in isolaat | |||
| 10005-7 | R wave dur L-V2 | duración de la onda R.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V2 | ||||
| 100057-9 | Prothionamid-Empfindlichkeit | Prothionamid [Empfindlichkeit] | Susceptibility to Prothionamide | Protionamide [Sensibilité] Isolat ; Alphanumérique | Prothionamide [gevoeligheid] in isolaat | |||
| 100058-7 | Prulifloxacin-Empfindlichkeit | Prulifloxacin [Empfindlichkeit] | Susceptibility to Prulifloxacin | Prulifloxacine [Sensibilité] Isolat ; Alphanumérique | Prulifloxacine [gevoeligheid] in isolaat | |||
| 100059-5 | Rifapentin-Empfindlichkeit | Rifapentin [Empfindlichkeit] | Susceptibility to Rifapentine | Rifapentine [Sensibilité] Isolat ; Alphanumérique | Rifapentine [gevoeligheid] in isolaat | |||
| 100060-3 | Tildipirosin-Empfindlichkeit | Susceptibility to Tildipirosin | Tildipirosine [Sensibilité] Isolat ; Alphanumérique | |||||
| 100061-1 | Tosufloxacin-Empfindlichkeit | Tosufloxacin [Empfindlichkeit] | Susceptibility to Tosufloxacin | Tosufloxacine [Sensibilité] Isolat ; Alphanumérique | Tosufloxacine [gevoeligheid] in isolaat | |||
| 100062-9 | SDOM panel | |||||||
| 100063-7 | Primary skin concern | |||||||
| 100064-5 | Itch severity RptPeriod Reported | |||||||
| 10006-5 | R wave dur L-V3 | duración de la onda R.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V3 | ||||
| 100065-2 | Satisfied with treatment | |||||||
| 100066-0 | Specular microscopy panel | Endotheelcelmicroscopie panel in oog d.m.v. endotheelcelmicroscopie | ||||||
| 100067-8 | Eye Image magnification | |||||||
| 100068-6 | R eye Fixation point [Angle] | |||||||
| 100069-4 | L eye Fixation point [Angle] | |||||||
| 100070-2 | R cornea Cell density | |||||||
| 100071-0 | L cornea Cell density | |||||||
| 100072-8 | R cornea Coefficient of variation | |||||||
| 10007-3 | R wave dur L-V4 | duración de la onda R.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V4 | ||||
| 100073-6 | L cornea Coefficient of variation | |||||||
| 100074-4 | R cornea Hexagonality | |||||||
| 100075-1 | L cornea Hexagonality | |||||||
| 100076-9 | R cornea Endothelial cells counted | |||||||
| 100077-7 | L cornea Endothelial cells counted | |||||||
| 100078-5 | R cornea Endothelial cell area.min | |||||||
| 100079-3 | L cornea Endothelial cell area.min | |||||||
| 100080-1 | R cornea Endothelial cell area.max | |||||||
| 10008-1 | R wave dur L-V5 | duración de la onda R.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V5 | ||||
| 100081-9 | L cornea Endothelial cell area.max | |||||||
| 100082-7 | R cornea Endothelial cell area.mean | |||||||
| 100083-5 | L cornea Endothelial cell area.mean | |||||||
| 100084-3 | R cornea Cell area.sd | |||||||
| 100085-0 | L cornea Cell area.sd | |||||||
| 100086-8 | R cornea Analysis method | |||||||
| 100087-6 | Toxocara canis 24-35kD IgG antibody, Blood | Toxocara canis 24-35kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxocara canis 24-35kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100088-4 | Taenia solium larva Ab bands panel, Blood | Taenia solium cysticerque Ac bandes panel [-] Sérum ; - ; Immunoblot | Taenia solium larve As banden panel in serum d.m.v. immunoblotting | |||||
| 100089-2 | Taenia solium larva 6-8kD antibody, Blood | Taenia solium cysticerque 6-8kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Taenia solium larve 6-8kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 1000-9 | DBG antibody, Blood Product Unit | [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma^unidad de hemoderivado:ordinal: | DBG Ab: Suero o plasma Unidad de hemoderivado: Punto temporal: Presencia o umbral: Ordinal: | DBG As [aanwezigheid] in serum of plasma^bloedproducteenheid | DBG Ac SerPl BPU Ql | |||
| 100090-0 | Taenia solium larva 45kD antibody, Blood | Taenia solium cysticerque 45kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Taenia solium larve 45kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100091-8 | Trypanosoma cruzi antibody, Blood | Trypanosoma cruzi Ac [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse | Trypanosoma cruzi As [eenheid/volume] in serum d.m.v. immunoassay | |||||
| 100092-6 | Trypanosoma cruzi Ab bands panel, Blood | Trypanosoma cruzi Ac bandes panel [-] Sérum ; - ; Immunoblot | Trypanosoma cruzi As banden panel in serum d.m.v. immunoblotting | |||||
| 100093-4 | Trypanosoma cruzi 15-16kD IgG antibody, Blood | Trypanosoma cruzi 15-16kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 15-16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100094-2 | Trypanosoma cruzi 21-22kD IgG antibody, Blood | Trypanosoma cruzi 21-22kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 21-22kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100095-9 | Trypanosoma cruzi 27-28kD IgG antibody, Blood | Trypanosoma cruzi 27-28kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100096-7 | Trypanosoma cruzi 42kD IgG antibody, Blood | Trypanosoma cruzi 42kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 42kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100097-5 | Trypanosoma cruzi 45-47kD IgG antibody, Blood | Trypanosoma cruzi 45-47kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 45-47kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100098-3 | Trypanosoma cruzi 120-200kD IgG antibody, Blood | Trypanosoma cruzi 120-200kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 120-200kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 10009-9 | R wave dur L-V6 | duración de la onda R.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V6 | ||||
| 100099-1 | Trypanosoma cruzi 160kD IgG antibody, Blood | Trypanosoma cruzi 160kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 160kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100100-7 | Fasciola sp IgG antibody, Blood | Fasciola Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse | Fasciola sp. As.IgG [aanwezigheid] in serum d.m.v. immunoassay | |||||
| 100101-5 | Fasciola sp 8-9kD IgG antibody, Blood | Fasciola 8-9kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Fasciola sp. 8-9kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100102-3 | Fasciola sp 27-28kD IgG antibody, Blood | Fasciola 27-28kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Fasciola sp. 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100103-1 | Fasciola sp 60kD IgG antibody, Blood | Fasciola 60kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Fasciola sp. 60kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100104-9 | Fasciola sp 42kD IgG antibody, Blood | Fasciola 42kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Fasciola sp. 42kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100105-6 | Filaria IgG and IgM panel, Blood | Filaria Ac IgG et IgM panel [-] Sérum ; - | Filaria As.IgG & IgM panel in serum | |||||
| 100106-4 | Filaria IgG antibody, Blood | Filaria Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse | Filaria As.IgG [aanwezigheid] in serum d.m.v. immunoassay | |||||
| 10010-7 | R' wave Amp L-AVF | amplitud de la onda R'.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-AVF | ||||
| 100107-2 | Leishmania sp IgG antibody, Blood | Leishmania Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse | Leishmania sp. As.IgG [aanwezigheid] in serum d.m.v. immunoassay | |||||
| 100108-0 | Leishmania sp IgG antibody, Blood | Leishmania Ac IgG [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse | Leishmania sp. As.IgG [eenheid/volume] in serum d.m.v. immunoassay | |||||
| 100109-8 | Leishmania sp Ab bands panel, Blood | Leishmania Ac bandes panel [-] Sérum ; - ; Immunoblot | Leishmania sp. As banden panel in serum d.m.v. immunoblotting | |||||
| 100110-6 | Leishmania sp 14kD IgG antibody, Blood | Leishmania 14 kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Leishmania sp. 14kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100111-4 | Leishmania sp 16kD IgG antibody, Blood | Leishmania 16 kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Leishmania sp. 16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100112-2 | Fasciola sp Ab bands panel, Blood | Fasciola Ac bandes panel [-] Sérum ; - ; Immunoblot | Fasciola sp. As-banden panel in serum d.m.v. immunoblotting | |||||
| 100113-0 | Helicobacter pylori Ab panel, Blood | Helicobacter pylori Ac panel [-] Sérum ; - | Helicobacter pylori As panel in serum | |||||
| 100114-8 | Toxoplasma gondii 30kD antibody, Blood | Toxoplasma gondii 30kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 30kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 10011-5 | R' wave Amp L-AVL | amplitud de la onda R'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-AVL | ||||
| 100115-5 | Toxoplasma gondii 31kD antibody, Blood | Toxoplasma gondii 31kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 31kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100116-3 | Toxoplasma gondii 33kD antibody, Blood | Toxoplasma gondii 33kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 33kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100117-1 | Toxoplasma gondii 40kD antibody, Blood | Toxoplasma gondii 40kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 40kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100118-9 | Toxoplasma gondii 41kD antibody, Blood | Toxoplasma gondii 41kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 41kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100119-7 | Toxoplasma gondii 45kD antibody, Blood | Toxoplasma gondii 45kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 45kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100120-5 | Chlamydia trachomatis Ab panel, Blood | Chlamydia trachomatis Ac panel [-] Sérum ; - | Chlamydia trachomatis As panel in serum | |||||
| 100121-3 | Chlamydia trachomatis IgA-Antikörper [Nachweis] in Serum mittels Immunoassay | Chlamydia trachomatis IgA antibody, Blood | Chlamydia trachomatis Ac IgA [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse | Chlamydia trachomatis As.IgA [aanwezigheid] in serum d.m.v. immunoassay | ||||
| 100122-1 | C. pneumoniae Ab panel, Blood | Chlamydia pneumoniae Ac panel [-] Sérum ; - | Chlamydophila pneumoniae As panel in serum | |||||
| 10012-3 | R' wave Amp L-AVR | amplitud de la onda R'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-AVR | ||||
| 100123-9 | Chlamydophila pneumoniae IgA antibody, Blood | Chlamydia pneumoniae Ac IgA [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse | Chlamydophila pneumoniae As.IgA [aanwezigheid] in serum d.m.v. immunoassay | |||||
| 100124-7 | Chlamydophila pneumoniae IgA antibody, Blood | Chlamydia pneumoniae Ac IgA [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse | Chlamydophila pneumoniae As.IgA [eenheid/volume] in serum d.m.v. immunoassay | |||||
| 100125-4 | C. psittaci Ab panel, Blood | Chlamydia psittaci Ac panel [-] Sérum ; - | Chlamydophila psittaci As panel in serum | |||||
| 100126-2 | Bordetella pertussis Ab.IgG panel, Blood | Bordetella pertussis Ac IgG panel [-] Sérum ; - | Bordetella pertussis As.IgG panel in serum | |||||
| 100127-0 | Campylobacter sp Ab panel, Blood | Campylobacter Ac panel [-] Sérum ; - | Campylobacter sp. As panel in serum | |||||
| 100128-8 | Cryptococcus sp Ag panel, Blood | Cryptococcus Ag panel [-] Sérum ; - | Cryptococcus sp. Ag panel in serum | |||||
| 100129-6 | Schistosoma sp antibody, Blood | Schistosoma Ac [Titre] Sérum ; Numérique ; Hémagglutination | Schistosoma sp. As [titer] in serum d.m.v. hemagglutinatie | |||||
| 100130-4 | Schistosoma mansoni antibody, Blood | Schistosoma mansoni Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma mansoni As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 10013-1 | R' wave Amp L-I | amplitud de la onda R'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de la onda R '. I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-I | ||||
| 100131-2 | Schistosoma sp 8kD antibody, Blood | Schistosoma 8kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 8kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100132-0 | Schistosoma sp 9kD antibody, Blood | Schistosoma 9kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 9kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100133-8 | Schistosoma sp 10kD antibody, Blood | Schistosoma 10kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 10kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100134-6 | Schistosoma sp 11kD antibody, Blood | Schistosoma 11kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 11kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100135-3 | Schistosoma sp 12-13kD antibody, Blood | Schistosoma 12-13kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 12-13kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100136-1 | Schistosoma sp 14-15kD antibody, Blood | Schistosoma 14-15kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 14-15kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100137-9 | Schistosoma sp 15-16kD antibody, Blood | Schistosoma 15-16kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 15-16kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100138-7 | Schistosoma sp 18-19kD antibody, Blood | Schistosoma 18-19kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 18-19kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100139-5 | Schistosoma sp 22-24kD antibody, Blood | Schistosoma 22-24kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 22-24kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100140-3 | Schistosoma sp 30-34kD antibody, Blood | Schistosoma 30-34kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 30-34kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100141-1 | Schistosoma sp 65kD antibody, Blood | Schistosoma 65kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 65kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100142-9 | Schistosoma sp 70kD antibody, Blood | Schistosoma 70kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 70kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100143-7 | Schistosoma sp 80kD antibody, Blood | Schistosoma 80kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 80kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100144-5 | Schistosoma sp 95kD antibody, Blood | Schistosoma 95kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 95kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100145-2 | Schistosoma sp 110kD antibody, Blood | Schistosoma 110kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 110kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100146-0 | Schistosoma sp 120kD antibody, Blood | Schistosoma 120kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 120kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100147-8 | Toxoplasma gondii Ab bands panel, Blood | Toxoplasma gondii Ac bandes panel [-] Sérum ; - ; Immunoblot | Toxoplasma gondii As banden panel in serum d.m.v. immunoblotting | |||||
| 100148-6 | Schistosoma sp Ab bands panel, Blood | Schistosoma Ac bandes panel [-] Sérum ; - ; Immunoblot | Schistosoma sp. As banden panel in serum d.m.v. immunoblotting | |||||
| 10014-9 | R' wave Amp L-II | amplitud de la onda R'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-II | ||||
| 100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel, Urine+Blood | 6-oxo-pipéridine-2-carboxylate et 6(R+S)-oxo-propylpipéridine-2-carboxylate panel [-] Urine+Sérum/Plasma ; - | 6-oxo-piperidine-2-carboxylaat & 6(R+S)-oxo-propylpiperidine-2-carboxylaat in urine en serum of plasma | |||||
| 100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate, Blood | 6(R+S)-oxo-propylpipéridine-2-carboxylate [Moles/Volume] Plasma ; Numérique | 6(R+S)-oxo-propylpiperidine-2-carboxylaat [mol/volume] in plasma | |||||
| 100151-0 | 6-oxo-piperidine-2-carboxylate, Blood | 6-oxo-pipéridine-2-carboxylate [Moles/Volume] Plasma ; Numérique | 6-oxo-piperidine-2-carboxylaat [mol/volume] in plasma | |||||
| 100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine, Urine | 6-oxo-pipéridine-2-carboxylate/créatinine [Moles ratio] Urine ; Numérique | 6-oxo-piperidine-2-carboxylaat/creatinine [molaire verhouding] in urine | |||||
| 100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine, Urine | 6(R+S)-oxo-propylpipéridine-2-carboxylate/créatinine [Moles ratio] Urine ; Numérique | 6(R+S)-oxo-propylpiperidine-2-carboxylaat/creatinine [molaire verhouding] in urine | |||||
| 100154-4 | Collection supervision level, Specimen | Niveau de supervision du recueil [Recherche] Prélèvement ; Résultat nominal | ||||||
| 100155-1 | L cornea Analysis method | |||||||
| 10015-6 | R' wave Amp L-III | amplitud de la onda R'.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-III | ||||
| 100156-9 | SARS-CoV-2 (COVID-19)-Variante [Typ] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | SARS-CoV-2 (COVID-19) variant, Specimen | Coronavirus SARS-CoV-2 variant [Type] Milieux divers ; Résultat nominal ; PCR amplification de cible | SARS-CoV-2-variant [type] d.m.v. probe-detectie | ||||
| 100157-7 | SARS-CoV-2 (COVID-19)-Abstammungslinie [Typ] in Probenmaterial mittels Sequenzierung | SARS-CoV-2 (COVID-19) lineage, Specimen | Coronavirus SARS-CoV-2 lignée [Type] Milieux divers ; Résultat nominal ; Séquençage | SARS-CoV-2 lineage [type] d.m.v. sequencing | ||||
| 100158-5 | Albumin, Urine | Albumine [Masse/Volume] Temps non précisé ; Urine ; Numérique ; Limite de détection<=20mg/L | Albumine [massa/volume] in urine (verzamelduur niet gespecificeerd) d.m.v. detectielimiet <= 20 mg/L | |||||
| 100159-3 | Knee Society Score pre-op panel [Knee Society Score] | |||||||
| 100160-1 | Knee replacement | |||||||
| 100161-9 | Charnley Functional Classification | |||||||
| 100162-7 | Alignment W Stand Knee XR | |||||||
| 100163-5 | Knee medial AndOr lateral instability W full extension | |||||||
| 10016-4 | R' wave Amp L-V1 | amplitud de la onda R'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V1 | ||||
| 100164-3 | Knee AP instability W 90 degree flexion | |||||||
| 100165-0 | Knee Qn | |||||||
| 100166-8 | Flexion contracture range Knee | |||||||
| 100167-6 | Extensor lag range Knee | |||||||
| 100168-4 | Knee pain severity with level walking | |||||||
| 100169-2 | Knee pain severity with stairs or inclines | |||||||
| 1001-7 | DBG antibody, Donor Blood | [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:relación suero/plasma^donante:ordinal: | DBG Ab: Suero o plasma Donante: Punto temporal: Presencia o umbral: Ordinal: | DBG As [aanwezigheid] in serum of plasma^donor | DBG Ac SerPl Donr Ql | |||
| 100170-0 | Knee feels normal | |||||||
| 100171-8 | Satisfaction with level of knee pain while sitting | |||||||
| 10017-2 | R' wave Amp L-V2 | amplitud de la onda R'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V2 | ||||
| 100172-6 | Satisfaction with level of knee pain while lying in bed | |||||||
| 100173-4 | Satisfaction with knee function while getting out of bed | |||||||
| 100174-2 | Satisfaction with knee function while performing light household duties | |||||||
| 100175-9 | Satisfaction with knee function while performing recreational activities | |||||||
| 100176-7 | Expect surgery to relieve pain | |||||||
| 100177-5 | Expect surgery will improve ability to perform activities of daily living | |||||||
| 100178-3 | Expect surgery will improve ability to perform leisure, recreational, or sports activities | |||||||
| 100179-1 | Walk without assistive mobility devices | |||||||
| 10018-0 | R' wave Amp L-V3 | amplitud de la onda R'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V3 | ||||
| 100180-9 | Assistive mobility devices used | |||||||
| 100181-7 | Assistive mobility devices used due to health condition | |||||||
| 100182-5 | Duration of standing before sitting due to knee discomfort | |||||||
| 100183-3 | Duration of walking before stopping due to knee discomfort | |||||||
| 100184-1 | How bothersome is knee when walking on an uneven surface | |||||||
| 100185-8 | How bothersome is knee when turning or pivoting leg | |||||||
| 100186-6 | How bothersome is knee when climbing up or down a flight of stairs | |||||||
| 100187-4 | How bothersome is knee when getting up from a low seat without armrests | |||||||
| 100188-2 | How bothersome is knee when getting into or out of a car | |||||||
| 100189-0 | How bothersome is knee when moving laterally | |||||||
| 100190-8 | How bothersome is knee when climbing a ladder or step stool | |||||||
| 100191-6 | How bothersome is knee when carrying a bag for one block | |||||||
| 100192-4 | How bothersome is knee when squatting | |||||||
| 100193-2 | How bothersome is knee when kneeling | |||||||
| 100194-0 | How bothersome is knee when running | |||||||
| 100195-7 | Pain severity--during activity | |||||||
| 100196-5 | Pre-op total score [Knee Society Score] | |||||||
| 100197-3 | Exercise activity and pain severity panel | |||||||
| 10019-8 | R' wave Amp L-V4 | amplitud de la onda R'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V4 | ||||
| 100198-1 | Pre-op objective knee indicators score [Knee Society Score] | |||||||
| 100199-9 | Pre-op symptoms score [Knee Society Score] | |||||||
| 100200-5 | Pre-op patient expectations score [Knee Society Score] | |||||||
| 100201-3 | Pre-op functional activities score [Knee Society Score] | |||||||
| 100202-1 | Pre-op discretionary knee activities score [Knee Society Score] | |||||||
| 100203-9 | Knee Society Score post-op panel [Knee Society Score] | |||||||
| 100204-7 | Accuracy of pre-surgery expectations of pain relief | |||||||
| 100205-4 | Accuracy of pre-surgery expectations to perform activities of daily living | |||||||
| 10020-6 | R' wave Amp L-V5 | amplitud de la onda R'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V5 | ||||
| 100206-2 | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities | |||||||
| 100207-0 | Post-op total score [Knee Society Score] | |||||||
| 100208-8 | Post-op objective knee indicators score [Knee Society Score] | |||||||
| 100209-6 | Post-op symptoms score [Knee Society Score] | |||||||
| 100210-4 | Post-op patient expectations score [Knee Society Score] | |||||||
| 100211-2 | Post-op functional activities score [Knee Society Score] | |||||||
| 100212-0 | Post-op discretionary knee activities score [Knee Society Score] | |||||||
| 100213-8 | Prostate cancer multigene analysis, Blood or tissue specimen | Analyse multigénique du cancer de la prostate [Recherche] Sang/Tissu ; Document ; Biologie moléculaire | Prostaatkanker multigen-analyse [bevinding] in bloed of weefsel d.m.v. moleculair genetisch onderzoek (document) | |||||
| 10021-4 | R' wave Amp L-V6 | amplitud de la onda R'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V6 | ||||
| 100214-6 | Dental model prior auth Doc | |||||||
| 100215-3 | Episode of care med rec Doc Transpl surg | Verslag van zorgepisode [bevinding] d.m.v. transplantatiechirurgie (document) | ||||||
| 100216-1 | Surgical synoptic report | Beknopt rapport [bevinding] d.m.v. chirurgie (tekstueel) | ||||||
| 100217-9 | Synoptic report Surg Onc | |||||||
| 100218-7 | Surg onc colon CA synoptic rep | |||||||
| 100219-5 | Surg onc melanoma CA synoptic rep | |||||||
| 100220-3 | Surg onc breast CA synoptic rep | |||||||
| 100221-1 | Surg onc thyroid CA synoptic rep | |||||||
| 10022-2 | R' wave dur L-AVF | duración de la onda R'.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-AVF | ||||
| 100222-9 | Surg onc pancreas CA synoptic rep | |||||||
| 100223-7 | Retina Phys find | |||||||
| 100224-5 | Cardiac LV SWM Pnl LV US | |||||||
| 100225-2 | Bone density QUS | |||||||
| 100226-0 | Sm bowel capsule endo study Doc | |||||||
| 100227-8 | Colon capsule endo study Doc | |||||||
| 100228-6 | UGI capsule endo study Doc | |||||||
| 100229-4 | Endo US study Doc | |||||||
| 10023-0 | R' wave dur L-AVL | duración de la onda R'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-AVL | ||||
| 100230-2 | Routine prenatal pnl | |||||||
| 100231-0 | EBUS study | |||||||
| 100232-8 | Impacts of Events Scale-Revised panel | |||||||
| 100233-6 | Reminders brought back feelings about adverse event | |||||||
| 100234-4 | Trouble staying asleep | |||||||
| 100235-1 | Other things triggered persistent thoughts about adverse event | |||||||
| 100236-9 | Felt irritable AndOr angry | |||||||
| 100237-7 | Avoided getting upset when unintentionally thought about adverse event | |||||||
| 100238-5 | Thought about adverse event unintentionally | |||||||
| 100239-3 | Felt as if adverse event did not happen | |||||||
| 100240-1 | Avoided reminders of adverse event | |||||||
| 100241-9 | Experienced mental images of adverse event | |||||||
| 100242-7 | Easily startled | |||||||
| 100243-5 | Tried to not think of adverse event | |||||||
| 100244-3 | Aware of feelings about adverse event, but did not address them | |||||||
| 100245-0 | Feelings about adverse event were numb | |||||||
| 100246-8 | Acted or felt the same as during adverse event | |||||||
| 100247-6 | Trouble falling asleep | |||||||
| 10024-8 | R' wave dur L-AVR | duración de la onda R'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-AVR | ||||
| 100248-4 | Waves of strong feelings about adverse event | |||||||
| 100249-2 | Tried to remove adverse event from memory | |||||||
| 1002-5 | DBG antibody, Blood | [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | DBG Ab: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | DBG As [aanwezigheid] in serum of plasma | DBG Ac SerPl Ql | |||
| 100250-0 | Trouble concentrating | |||||||
| 100251-8 | Reminders of adverse event caused physical reactions | |||||||
| 100252-6 | Had dreams about adverse event | |||||||
| 100253-4 | Felt watchful and on-guard | |||||||
| 100254-2 | Tried not to talk about adverse event | |||||||
| 10025-5 | R' wave dur L-I | duración de la onda R'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R '.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-I | ||||
| 100255-9 | Total score [Impact of Event Scale-Revised] | |||||||
| 100256-7 | Fallen in last 6Mo | |||||||
| 100257-5 | Feel unsteady when standing or walking | |||||||
| 100258-3 | History of fall related injury | |||||||
| 100259-1 | Aware of tactile sensations | |||||||
| 100260-9 | Easy to describe thoughts AndOr feelings | |||||||
| 100261-7 | Critical of own thoughts AndOr feelings | |||||||
| 100262-5 | Able to notice distressing thoughts AndOr feelings without having to react | |||||||
| 10026-3 | R' wave dur L-II | duración de la onda R'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-II | ||||
| 100263-3 | Easily distracted | |||||||
| 100264-1 | Able to notice thoughts AndOr feelings without being overwhelmed | |||||||
| 100265-8 | Aware of dietary intake impact on self | |||||||
| 100266-6 | Difficult to describe thoughts AndOr feelings | |||||||
| 100267-4 | Aware of auditory stimuli | |||||||
| 100268-2 | Able to avoid immediate reaction in difficult situations | |||||||
| 100269-0 | Do things without paying attention | |||||||
| 100270-8 | Recover quickly from distressing thoughts AndOr images | |||||||
| 10027-1 | R' wave dur L-III | duración de la onda R'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-III | ||||
| 100271-6 | Aware of olfactory stimuli | |||||||
| 100272-4 | Aware of visual stimuli | |||||||
| 100273-2 | Aware of emotions affect on thoughts AndOr behavior | |||||||
| 100274-0 | Observing score [FFMQ] | |||||||
| 100275-7 | Describing score [FFMQ] | |||||||
| 100276-5 | Acting with awareness score [FFMQ] | |||||||
| 100277-3 | Nonjudging score [FFMQ] | |||||||
| 100278-1 | Nonreactivity score [FFMQ] | |||||||
| 100279-9 | Total score [FFMQ] | |||||||
| 100280-7 | Five Facet Mindfulness Questionnaire panel [FFMQ] | |||||||
| 100281-5 | D antibody, Blood | RH1 (D) anticorps [Arbitraire/Volume] Sérum/Plasma ; Numérique | D As [eenheid/volume] in serum of plasma | |||||
| 100282-3 | Vaccine exemption cert | |||||||
| 100283-1 | Harris Hip Score panel [Harris Hip Score] | |||||||
| 100284-9 | Walking - functional ability | |||||||
| 100285-6 | Comfortable seated position | |||||||
| 100286-4 | Able to board public transportation | |||||||
| 100287-2 | Put on shoes and socks | |||||||
| 100288-0 | Absence of deformity score [Harris Hip Score] | |||||||
| 10028-9 | R' wave dur L-V1 | duración de la onda R'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V1 | ||||
| 100289-8 | Absence of hip deformity measurements | |||||||
| 100290-6 | Range of motion score [Harris Hip Score] | |||||||
| 100291-4 | Total score [Harris Hip Score] | |||||||
| 100292-2 | Pre-op patient satisfaction score [Knee Society Score] | |||||||
| 100293-0 | Hip Flexion range of motion | |||||||
| 100294-8 | Hip Abduction range of motion | |||||||
| 100295-5 | Hip Adduction range of motion | |||||||
| 100296-3 | Hip External rotation range of motion | |||||||
| 10029-7 | R' wave dur L-V2 | duración de la onda R'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V2 | ||||
| 100297-1 | Hip Internal rotation range of motion | |||||||
| 100298-9 | Rep count | |||||||
| 100299-7 | Post-op patient satisfaction score [Knee Society Score] | |||||||
| 100300-3 | End time | |||||||
| 100301-1 | Start time | |||||||
| 100302-9 | Time start/end panel Spec | |||||||
| 100303-7 | Condition certainty of presence | |||||||
| 100304-5 | Flights climbed RptPeriod | |||||||
| 10030-5 | R' wave dur L-V3 | duración de la onda R'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V3 | ||||
| 100305-2 | IDH1 gene exon 4 targeted mutation analysis, Blood Or Bone marrow | IDH1 gène exon 4 mutation cible trouvée [Présence/Seuil] Sang/Moelle osseuse ; Qualitatif ; Biologie moléculaire | IDH1-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek | |||||
| 100306-0 | IDH2 gene exon 4 targeted mutation analysis, Blood Or Bone marrow | IDH2 gène exon 4 mutation cible trouvée [Présence/Seuil] Sang/Moelle osseuse ; Qualitatif ; Biologie moléculaire | IDH2-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek | |||||
| 100307-8 | Behavioral screening elder mistreatment | |||||||
| 100308-6 | Need help getting to essential places | |||||||
| 100309-4 | Activity support person | |||||||
| 100310-2 | Reliability of support person | |||||||
| 100311-0 | Need help to make sure there is enough food, medicines or any other things needed in house | |||||||
| 100312-8 | Person or persons that makes sure there is enough food, medicines or any other things needed in house | |||||||
| 10031-3 | R' wave dur L-V4 | duración de la onda R'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V4 | ||||
| 100313-6 | Need help with household things such as cook meals, help feed, or provide correct medicines each day | |||||||
| 100314-4 | Need help with house cleaning or yard work | |||||||
| 100315-1 | Need help getting out of bed, showered, or dressed | |||||||
| 100316-9 | Need help to make sure bills get paid | |||||||
| 100317-7 | Relationship of usual support person for daily activities | |||||||
| 100318-5 | Have help with finances AndOr financial decisions | |||||||
| 100319-3 | Relationship of financial support person | |||||||
| 100320-1 | Financial support person usually asks for permission before making decisions | |||||||
| 10032-1 | R' wave dur L-V5 | duración de la onda R'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V5 | ||||
| 100321-9 | Financial support person usually makes good decisions about finances | |||||||
| 100322-7 | Have access to paperwork for financial decisions made | |||||||
| 100323-5 | Financial support person forged signature | |||||||
| 100324-3 | Coercion of financial support person for signing a document in order to get money or possessions | |||||||
| 100325-0 | Experienced theft by support person | |||||||
| 100326-8 | Money spent or property sold without permission | |||||||
| 100327-6 | Stranger forged signature for financial gain | |||||||
| 100328-4 | Stranger forced document signature for financial gain | |||||||
| 100329-2 | Feared for safety due to verbal attack | |||||||
| 1003-3 | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | Prueba de antiglobulina indirecta, reactivo específico del complemento: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | Test indirect à l'antiglobuline (TIA) complément spécifique [Présence/Seuil] Sérum/Plasma ; Qualitatif | Indirecte antiglobulinetest.complement-specifiek reagent [aanwezigheid] in serum of plasma | IAT Comp-Sp Reag SerPl Ql | ||
| 100330-0 | Felt humiliated due to ridicule | |||||||
| 100331-8 | Coerced to do something | |||||||
| 100332-6 | Ignored by close friend or relative for extended period | |||||||
| 100333-4 | Physically hit or threatened | |||||||
| 100334-2 | Been physically hurt with some degree of injury | |||||||
| 100335-9 | Coerced sexual activity | |||||||
| 100336-7 | Coerced touching of private body parts of self or others | |||||||
| 100337-5 | Coerced to undress or expose private body area | |||||||
| 100338-3 | Photographed in any degree of nudity without consent | |||||||
| 10033-9 | R' wave dur L-V6 | duración de la onda R'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V6 | ||||
| 100339-1 | Experienced attempted physical restraint | |||||||
| 100340-9 | Range of motion panel Hip | |||||||
| 100341-7 | Rötelnvirus Antikörper-Index | Röteln-Virus IgG-Antikörperindex [Einheiten/Volumen] in Serum und Liquor | Rubella virus IgG index, Serum+Cerebrospinal fluid | Rubéole virus Ac IgG index [Arbitraire/Volume] Sérum+Liquide céphalorachidien ; Numérique | Rubellavirus As.IgG-index [eenheid/volume] in serum en liquor cerebrospinalis | |||
| 100342-5 | Flüchtige organische Verbindungen assoziiert mit SARS-CoV-2-Infektion [Nachweis] in Exhalat mittels GC-MS | Volatile Organic Compounds associated with SARS-CoV-2 infection, Exhaled gas | Composés organiques volatiles associés à l'infection SARS-CoV-2 [Présence/Seuil] Gaz expiré ; Qualitatif | Vluchtige organische componenten bij SARS-CoV-2-infectie [aanwezigheid] in uitgeademde lucht d.m.v. gaschromatografie-massaspectrometrie | ||||
| 100343-3 | Influenza-Virus B RNA [Nachweis] in Speichel mittels Nukleinsäureamplifikation mit Sondendetektion | Influenza B (Flu B), Saliva | Influenza virus B ARN [Présence/Seuil] Salive ; Qualitatif ; PCR amplification de cible | Influenzavirus B RNA [aanwezigheid] in speeksel d.m.v. probe-detectie | ||||
| 100344-1 | Influenza-Virus A RNA [Nachweis] in Speichel mittels Nukleinsäureamplifikation mit Sondendetektion | Influenza A (Flu A), Saliva | Influenza virus A ARN [Présence/Seuil] Salive ; Qualitatif ; PCR amplification de cible | Influenzavirus A RNA [aanwezigheid] in speeksel d.m.v. probe-detectie | ||||
| 100345-8 | Influenza-Virus A und Influenza-Virus B und SARS-CoV-2 (COVID-19) RNA (Liste) - Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel, Specimen | Influenza virus A et B et Coronavirus SARS-Cov-2 ARN panel [-] Milieux divers ; - ; PCR amplification de cible | Influenzavirus A & influenzavirus B & SARS-CoV-2 RNA panel d.m.v. probe-detectie | ||||
| 100346-6 | Clotting time.extrinsic coagulation system activated.platelets inhibited, Blood | Temps de coagulation (activation de la voie extrinsèque) avec inhibition des plaquettes [Temps] Sang ; Numérique ; Thromboélastographie rotationelle | ||||||
| 10034-7 | S wave Amp L-AVF | amplitud de la onda S.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVF | ||||
| 100347-4 | Clot formation.extrinsic coagulation system activated.platelets inhibited, Blood | Temps de formation du caillot (activation de la voie extrinsèque) avec inhibition des plaquettes [Temps] Sang ; Numérique ; Thromboélastographie rotationelle | ||||||
| 100348-2 | MELDNa score | |||||||
| 100349-0 | DOP Penis ves W vasodilator IV | |||||||
| 100350-8 | Sesamum indicum 1 allergy test | Sésame (graine) 1 Ac IgE [Arbitraire/Volume] Sérum ; Numérique | Sesamum indicum 1 As.IgE [eenheid/volume] in serum | |||||
| 100351-6 | Pioglitazone, Blood | Pioglitazone [Présence/Seuil] Sérum/Plasma ; Qualitatif | Pioglitazon [aanwezigheid] in serum of plasma | |||||
| 100352-4 | Rosiglitazone, Blood | Rosiglitazone [Présence/Seuil] Sérum/Plasma ; Qualitatif | Rosiglitazon [aanwezigheid] in serum of plasma | |||||
| 100353-2 | Norwalk Community Health Center Screening Tool [NCHC] | |||||||
| 10035-4 | S wave Amp L-AVL | amplitud de la onda S.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVL | ||||
| 100354-0 | Frequency of participating in multi-modal communication without assistance | |||||||
| 100355-7 | Frequency of participating in spoken language expression communication without assistance | |||||||
| 100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis, Specimen | Chlamydia trachomatis et Neisseria gonorrhoeae et Trichomonas vaginalis ADN [Identification] Milieux divers ; Résultat nominal ; PCR amplification de cible | Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA [identificator] d.m.v. probe-detectie | |||||
| 100357-3 | Naloxone, Umbilical cord tissue | Naloxone [Présence/Seuil] Tissu de cordon ; Qualitatif ; Dépistage | Naloxon [aanwezigheid] in weefsel van navelstreng d.m.v. screening | |||||
| 100358-1 | Phentermine, Umbilical cord tissue | Phentermine [Présence/Seuil] Tissu de cordon ; Qualitatif ; Dépistage | Fentermine [aanwezigheid] in weefsel van navelstreng d.m.v. screening | |||||
| 100359-9 | Gliadin 33 mer peptide, Stool | Gliadine 33-mer peptide [Masse/Volume] Selle ; Numérique ; Immunoanalyse | Gliadin 33-mer peptide [massa/volume] in feces d.m.v. immunoassay | |||||
| 100360-7 | Brief Resilience Scale panel [BRS] | |||||||
| 100361-5 | Quickly recover from bad events | |||||||
| 10036-2 | S wave Amp L-AVR | amplitud de la onda S.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVR | ||||
| 100362-3 | Difficulty making it through stressful events | |||||||
| 100363-1 | Easily recover from a stressful event | |||||||
| 100364-9 | Difficulty recovering from bad events | |||||||
| 100365-6 | Easily recover from difficulties | |||||||
| 100366-4 | Lengthy recovery from setbacks | |||||||
| 100367-2 | Total Score BRS | |||||||
| 100368-0 | Amino Acids Urea Cycle Panel, Blood | Acides aminés du cycle de l'urée panel [-] Sérum/Plasma ; - ; LC/MS/MS | Aminozuren ureumcyclus panel in serum of plasma d.m.v. LC/MS/MS | |||||
| 100369-8 | NM Thyroid Views W Tl-201 IV | |||||||
| 10037-0 | S wave Amp L-I | amplitud de la onda S.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de la onda S. Conduzca I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-I | ||||
| 100370-6 | Orthopoxvirus DNA [Nachweis oder Identität] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Orthopoxvirus, Specimen | Orthopoxvirus ADN [Identification] Milieux divers ; Résultat nominal ; PCR amplification de cible | Orthopoxvirus DNA [identificator] d.m.v. probe-detectie | ||||
| 100371-4 | Titin antibody, Blood | Titine anticorps [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse | ||||||
| 100372-2 | Abiraterone, Blood | Abiratérone [Masse/Volume] Sérum/Plasma ; Numérique | Abirateron [massa/volume] in serum of plasma | |||||
| 100373-0 | Agar- agar IgG antibody | Eucheuma Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Eucheuma As.IgG [eenheid/volume] in serum | |||||
| 100374-8 | Aloe vera IgG antibody | Aloe vera Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Aloë vera As.IgG [eenheid/volume] in serum | |||||
| 100375-5 | Anise IgG antibody | Anis Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Pimpinella anisum As.IgG [eenheid/volume] in serum | |||||
| 100376-3 | Bambusa vulgaris IgG antibody | Bambou commun Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Bambusa vulgaris As.IgG [eenheid/volume] in serum | |||||
| 100377-1 | Goat cheese IgG antibody | Fromage de chèvre Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Geitenkaas As.IgG [eenheid/volume] in serum | |||||
| 100378-9 | Sheep cheese IgG antibody | Fromage de brebis Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Schapenkaas As.IgG [eenheid/volume] in serum | |||||
| 100379-7 | Leeks IgG antibody | Poireau vivace Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Allium ampeloprasum As.IgG [eenheid/volume] in serum | |||||
| 100380-5 | Red cabbage IgG antibody | Chou rouge Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Brassica rubra As.IgG [eenheid/volume] in serum | |||||
| 100381-3 | Mentha balsamea Wild IgG antibody | Menthe poivrée hybride Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Pepermunt As.IgG [eenheid/volume] in serum | |||||
| 100382-1 | FDA insert REMS addressed risk | |||||||
| 100383-9 | Affenpocken-Virus DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus, Specimen | Monkeypox virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Mpoxvirus DNA [aanwezigheid] d.m.v. probe-detectie | ||||
| 100384-7 | Rapeseed IgG antibody | Chou champêtre Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Brassica rapa As.IgG [eenheid/volume] in serum | |||||
| 100385-4 | Corn salad IgG antibody | Mâche Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Valerianella locusta As.IgG [eenheid/volume] in serum | |||||
| 100386-2 | Rosemary IgG antibody | Romarin Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Rosmarinus officinalis As.IgG [eenheid/volume] in serum | |||||
| 100387-0 | Poppy seed IgG antibody | Pavot (graine) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Papaver somniferum As.IgG [eenheid/volume] in serum | |||||
| 10038-8 | S wave Amp L-II | amplitud de la onda S.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-II | ||||
| 100388-8 | Cocoa IgG antibody | Cacao Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Theobroma cacao As.IgG [eenheid/volume] in serum | |||||
| 100389-6 | Pistachio IgG antibody | Pistache Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Pistacia vera As.IgG [eenheid/volume] in serum | |||||
| 100390-4 | Sunflower seed IgG antibody | Tournesol (graine) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Helianthus annuus zaad As.IgG [eenheid/volume] in serum | |||||
| 100391-2 | Dates IgG antibody | Datte Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Phoenix dactylifera As.IgG [eenheid/volume] in serum | |||||
| 100392-0 | Duck meat IgG antibody | Canard (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Eendenvlees As.IgG [eenheid/volume] in serum | |||||
| 100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG antibody | Allergène de champigons macroscopiques mix2 (Xerocomus, Boletus) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Paddenstoelallergenen mix 2 (Xerocomus + Boletus) As.IgG [eenheid/volume] in serum | |||||
| 100394-6 | Decapod crustaceans IgG antibody | Astacoidea Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Astacoidea As.IgG [eenheid/volume] in serum | |||||
| 100395-3 | Carob IgG antibody | Caroube Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Ceratonia siliqua As.IgG [eenheid/volume] in serum | |||||
| 10039-6 | S wave Amp L-III | amplitud de la onda S.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-III | ||||
| 100396-1 | Brassica napus IgG antibody | Colza Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Brassica napus As.IgG [eenheid/volume] in serum | |||||
| 100397-9 | Goat Meat IgG antibody | Bouquetin Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Geitenvlees As.IgG [eenheid/volume] in serum | |||||
| 100398-7 | Goose meat IgG antibody | Oie (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Ganzenvlees As.IgG [eenheid/volume] in serum | |||||
| 100399-5 | Ostrich meat IgG antibody | Autruche (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Struisvogelvlees As.IgG [eenheid/volume] in serum | |||||
| 100400-1 | Quail meat IgG antibody | Caille (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Kwartelvlees As.IgG [eenheid/volume] in serum | |||||
| 100401-9 | Rabbit meat IgG antibody | Lapin (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Konijnenvlees As.IgG [eenheid/volume] in serum | |||||
| 100402-7 | Venison meat IgG antibody | Venaison (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Hertenvlees As.IgG [eenheid/volume] in serum | |||||
| 100403-5 | Guineafowl IgG antibody | Pintade Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Parelhoen As.IgG [eenheid/volume] in serum | |||||
| 10040-4 | S wave Amp L-V1 | amplitud de la onda S.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V1 | ||||
| 100404-3 | Horse meat IgG antibody | Cheval (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Paardenvlees As.IgG [eenheid/volume] in serum | |||||
| 100405-0 | Kefir IgG antibody | Kefir Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Kefir As.IgG [eenheid/volume] in serum | |||||
| 100406-8 | Butter IgG antibody | Beurre Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Boter As.IgG [eenheid/volume] in serum | |||||
| 100407-6 | Camembert cheese IgG antibody | Fromage camembert Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Camembert As.IgG [eenheid/volume] in serum | |||||
| 100408-4 | Emmental cheese IgG antibody | Fromage emmental Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Emmentaler kaas As.IgG [eenheid/volume] in serum | |||||
| 100409-2 | Processed cheese IgG antibody | Fromage fondu Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Smeltkaas As.IgG [eenheid/volume] in serum | |||||
| 1004-1 | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: | Test de antiglobulina directo, reactivo específico del complemento: Eritrocitos : Punto temporal: Presencia o umbral: Ordinal: | Test direct à l'antiglobuline (EDA) complément spécifique [Présence/Seuil] Érythrocytes ; Qualitatif | Directe antiglobulinetest.complement specifiek reagens [aanwezigheid] in erytrocyten | DAT Comp-Sp Reag RBC Ql | ||
| 100410-0 | Curd cheese IgG antibody | Fromage blanc Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Kwark As.IgG [eenheid/volume] in serum | |||||
| 100411-8 | Sugar beet IgG antibody | Betterave sucrière Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Bèta-vulgaris As.IgG [eenheid/volume] in serum | |||||
| 10041-2 | S wave Amp L-V2 | amplitud de la onda S.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V2 | ||||
| 100412-6 | Chinese cabbage IgG antibody | Chou chinois Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Chinese kool As.IgG [eenheid/volume] in serum | |||||
| 100413-4 | Fennel fresh IgG antibody | Fenouil Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Foeniculum vulgare vers As.IgG [eenheid/volume] in serum | |||||
| 100414-2 | Gourd IgG antibody | Cucurbitaceae Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Genera in Cucurbitaceae As.IgG [eenheid/volume] in serum | |||||
| 100415-9 | Kale IgG antibody | Chou frisé Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Brassica oleracea var. Borecole As.IgG [eenheid/volume] in serum | |||||
| 100416-7 | Savoy cabbage IgG antibody | Chou de Milan [Arbitraire/Volume] Sérum ; Numérique | Brassica oleracea var. Sabauda As.IgG [eenheid/volume] in serum | |||||
| 100417-5 | Vitis sp leaf IgG antibody | Feuille de vigne Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Blad van Vitis sp. As.IgG [eenheid/volume] in serum | |||||
| 100418-3 | Liquorice IgG antibody | Réglisse Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Glycyrrhiza glabra As.IgG [eenheid/volume] in serum | |||||
| 100419-1 | Snow pea IgG antibody | Pois gourmand Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Pisum sativum var. saccharatum As.IgG [eenheid/volume] in serum | |||||
| 10042-0 | S wave Amp L-V3 | amplitud de la onda S.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V3 | ||||
| 100420-9 | Fava bean IgG antibody | Fève Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Vicia faba As.IgG [eenheid/volume] in serum | |||||
| 100421-7 | Chick pea IgG antibody | Pois chiche Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Cicer arietinus As.IgG [eenheid/volume] in serum | |||||
| 100422-5 | Chicory IgG antibody | Chicorée sauvage Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Cichorium intybus As.IgG [eenheid/volume] in serum | |||||
| 100423-3 | Button + oyster + Shiitaki + chanterelle mushroom IgG antibody | (Champignon de Paris+pleurote+lentin du chêne+catharelle) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Paddenstoelallergenen mix 1 (Agaricus bisporus + Pleurotus ostreatus + Lentinula edodes + Cantharellus) As.IgG [eenheid/volume] in serum | |||||
| 100424-1 | 8(9)-Cholestenol, Blood | 8(9)-cholesténol [Masse/Volume] Sérum/Plasma ; Numérique | 8(9)-cholestenol [massa/volume] in serum of plasma | |||||
| 100425-8 | DiHydro T-Mas, Blood | Dihydro T-Mas [Masse/Volume] Sérum/Plasma ; Numérique | DiHydro T-Mas [massa/volume] in serum of plasma | |||||
| 100426-6 | Squalene, Blood | Squalène [Masse/Volume] Sérum/Plasma ; Numérique | ||||||
| 100427-4 | Stigmasterol, Blood | Stigmastérol [Masse/Volume] Sérum/Plasma ; Numérique | Stigmasterol [massa/volume] in serum of plasma | |||||
| 100428-2 | Carnitine free and total and acylcarnitine panel, Urine | Carnitine libre et totale et acylcarnitine panel [-] Urine ; - | Carnitine.vrij & totaal & acylcarnitine panel in urine | |||||
| 100429-0 | LRBA deficiency panel, Blood | Déficience protéine LRBA panel [-] Sang ; - | LRBA-deficiëntie panel in bloed | |||||
| 100430-8 | Cells.LRBA+ 100 Cells.CD3+CD14-CD45+, Blood | LRBA+/100 cellules CD3+CD14-CD45+ [Fraction de nombres] Sang ; Numérique ; Cytométrie de flux | Cellen.LRBA+/100 cellen.CD3+CD14-CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie | |||||
| 100431-6 | T-cells LRBA MFI, Blood | CD3+CD14-CD45+LRBA intensité de fluorescence [Arbitraire] Sang ; Numérique ; Cytométrie de flux | Cellen.CD3+CD14-CD45+.LRBA gemiddelde fluorescentie-intensiteit [aanwezigheid] in bloed d.m.v. flowcytometrie | |||||
| 100432-4 | Cells.LRBA+ 100 Cells.CD3-CD14-CD19+CD45+, Blood | LRBA+/100 cellules CD3-CD14-CD19+CD45+ [Fraction de nombres] Sang ; Numérique ; Cytométrie de flux | Cellen.LRBA+/100 cellen.CD3-CD14-CD19+CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie | |||||
| 100433-2 | B-cells LRBA MFI, Blood | CD3-CD14-CD19+CD45+LRBA intensité de fluorescence [Arbitraire] Sang ; Numérique ; Cytométrie de flux | Cellen.CD3-CD14-CD19+CD45+.LRBA gemiddelde fluorescentie-intensiteit [aanwezigheid] in bloed d.m.v. flowcytometrie | |||||
| 100434-0 | Orthopoxvirus.nicht-variola DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Orthopoxvirus.non-variola, Specimen | Orthopoxvirus non variola ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Orthopoxvirus anders dan variolavirus DNA [aanwezigheid] d.m.v. probe-detectie | ||||
| 100435-7 | Glial fibrillary acidic protein, Blood | GFAP [Masse/Volume] Sérum ; Numérique ; Immunoanalyse | Gliaal fibrillair acidisch proteïne [massa/volume] in serum d.m.v. immunoassay | |||||
| 100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1, Blood | Ubiquitin carboxyl-terminal hydrolase-L1 [Masse/Volume] Sérum ; Numérique ; Immunoanalyse | ||||||
| 100437-3 | Norsufentanil, Urine | Norsufentanil [Masse/Volume] Urine ; Numérique ; Confirmation | Norsufentanil [massa/volume] in urine d.m.v. bevestiging | |||||
| 10043-8 | S wave Amp L-V4 | amplitud de la onda S.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V4 | ||||
| 100438-1 | Adolescent med OP Prog note | |||||||
| 100439-9 | Allergy+Immunology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. allergie+immunologie (document) | ||||||
| 100440-7 | Allergy OP Prog note | |||||||
| 100441-5 | Attend OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. behandelend arts (document) | ||||||
| 100442-3 | Audiology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. audiologie (document) | ||||||
| 100443-1 | Bariatric surg OP Prog note | |||||||
| 100444-9 | Bld Bnk+Trans Med OP Prog note | |||||||
| 100445-6 | BM Transplant OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. beenmergtransplantatie (document) | ||||||
| 10044-6 | S wave Amp L-V5 | amplitud de la onda S.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V5 | ||||
| 100446-4 | Breastfeeding OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. borstvoeding (document) | ||||||
| 100447-2 | Burn OP Prog note | |||||||
| 100448-0 | Cardiac surgery OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. cardiochirurgie (document) | ||||||
| 100449-8 | Cardio+Pulm disease OP Prog note | |||||||
| 100450-6 | Child+teen psych OP Prog note | |||||||
| 100451-4 | Chiropractic med OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. chiropractie (document) | ||||||
| 100452-2 | Electrophysiology OP Prog note | |||||||
| 10045-3 | S wave Amp L-V6 | amplitud de la onda S.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V6 | ||||
| 100453-0 | Clinical genetics OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. klinische genetica (document) | ||||||
| 100454-8 | Clinical Neurophys OP Prog note | |||||||
| 100455-5 | Clin Path OP Prog note | |||||||
| 100456-3 | Col+rec surg OP Prog note | |||||||
| 100457-1 | Consultant OP Prog note | |||||||
| 100458-9 | OP COVID-19 Intub+Progress | |||||||
| 100459-7 | OP COVID-19 Progress note | |||||||
| 100460-5 | Dermatology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. dermatologie (document) | ||||||
| 10046-1 | S wave dur L-AVF | duración de la onda S.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-AVF | ||||
| 100461-3 | Develop-behav peds OP Prog note | |||||||
| 100462-1 | Dialy+Ther Apher OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. dialyse en therapeutische aferese (document) | ||||||
| 100463-9 | Eating disorders OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. eetstoornis (document) | ||||||
| 100464-7 | Endocrinology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. endocrinologie (document) | ||||||
| 100465-4 | Fam Med OP Prog note | |||||||
| 100466-2 | Gastroenterology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. gastro-enterologie (document) | ||||||
| 100467-0 | Geri med OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. geriatrie (document) | ||||||
| 100468-8 | Gyn Onc OP Prog note | |||||||
| 100469-6 | Gynecology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. gynaecologie (document) | ||||||
| 100470-4 | Navigator OP Prog note | |||||||
| 100471-2 | Heart failure OP Prog note | |||||||
| 100472-0 | HF+TC OP Prog note | |||||||
| 100473-8 | Hematology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. hematologie (document) | ||||||
| 100474-6 | HemOnc OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. hematologie + oncologie (document) | ||||||
| 100475-3 | Hepatology OP Prog note | |||||||
| 100476-1 | Immunology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. immunologie (document) | ||||||
| 100477-9 | Infectious disease OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. infectioloog (document) | ||||||
| 100478-7 | Internal Med OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. interne geneeskunde (document) | ||||||
| 10047-9 | S wave dur L-AVL | duración de la onda S.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-AVL | ||||
| 100479-5 | IC OP Prog note | |||||||
| 100480-3 | IR OP Prog note | |||||||
| 100481-1 | OP MCS+progress note | |||||||
| 100482-9 | MAiD OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. medische zorg bij sterven (document) | ||||||
| 100483-7 | Mental health OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. geestelijke gezondheidszorg (document) | ||||||
| 100484-5 | Multi-spec prog OP Prog note | |||||||
| 100485-2 | Neo peri med OP Prog note | |||||||
| 100486-0 | Nephrology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. nefrologie (document) | ||||||
| 10048-7 | S wave dur L-AVR | duración de la onda S.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-AVR | ||||
| 100487-8 | Neuro surgery OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. neurochirurgie (document) | ||||||
| 100488-6 | Neurology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. neurologie (document) | ||||||
| 100489-4 | Child neuro OP Prog note | |||||||
| 100490-2 | Nurse pract OP Prog note | |||||||
| 100491-0 | Nurse OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. verpleegkundige (document) | ||||||
| 100492-8 | Nutr+diet OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. voeding en diëtetiek (document) | ||||||
| 100493-6 | OBGYN OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. obstetrie en gynaecologie (document) | ||||||
| 100494-4 | OB OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. obstetrie (document) | ||||||
| 10049-5 | S wave dur L-I | duración de la onda S.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Conduzca I:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-I | ||||
| 100495-1 | OT OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. bezigheidstherapie (document) | ||||||
| 100496-9 | Oncology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. oncologie (document) | ||||||
| 100497-7 | Ophthalmol OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. oogheelkunde (document) | ||||||
| 100498-5 | Optometry OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. optometrie (document) | ||||||
| 100499-3 | OMS OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. oromaxillofaciale chirurgie (document) | ||||||
| 100500-8 | Orthopaedic surgery OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. orthopedische chirurgie (document) | ||||||
| 100501-6 | Orthotics prosthetics OP Prog note | |||||||
| 100502-4 | Otolaryngology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. KNO (document) | ||||||
| 10050-3 | S wave dur L-II | duración de la onda S.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-II | ||||
| 100503-2 | Pain medicine OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. pijnbestrijding (document) | ||||||
| 100504-0 | Palliative care OP Prog note | |||||||
| 100505-7 | Peds cardiology OP Prog note | |||||||
| 100506-5 | Peds dermatology OP Prog note | |||||||
| 100507-3 | Peds endocrinology OP Prog note | |||||||
| 100508-1 | Peds gastroenterology OP Prog note | |||||||
| 100509-9 | Peds hem-onc OP Prog note | |||||||
| 100510-7 | Peds infect disease OP Prog note | |||||||
| 10051-1 | S wave dur L-III | duración de la onda S.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-III | ||||
| 100511-5 | Peds otolaryngology OP Prog note | |||||||
| 100512-3 | Peds pulmonology OP Prog note | |||||||
| 100513-1 | Peds rheumatology OP Prog note | |||||||
| 100514-9 | Peds surgery OP Prog note | |||||||
| 100515-6 | Peds transpl hepato OP Prog note | |||||||
| 100516-4 | Peds urology OP Prog note | |||||||
| 100517-2 | Pharmacogenomics OP Prog note | |||||||
| 100518-0 | PM+R OP Prog note | |||||||
| 100519-8 | PT OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. fysiotherapie (document) | ||||||
| 100520-6 | Plastic surgery OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. plastische chirurgie (document) | ||||||
| 100521-4 | Podiatry OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. podologie (document) | ||||||
| 100522-2 | Psychiatric Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. psychiatrie (document) | ||||||
| 100523-0 | Psych OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. psychologie (document) | ||||||
| 100524-8 | Pulmonary disease OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. longaandoening (document) | ||||||
| 100525-5 | Radiation Onc OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. radiotherapie (document) | ||||||
| 100526-3 | Radiology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. radiologie (document) | ||||||
| 100527-1 | Rec therapy OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. recreationele therapie (document) | ||||||
| 100528-9 | REI OP Prog note | |||||||
| 10052-9 | S wave dur L-V1 | duración de la onda S.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V1 | ||||
| 100529-7 | Research OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. wetenschappelijk onderzoek (document) | ||||||
| 100530-5 | Rheumatology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. reumatologie (document) | ||||||
| 100531-3 | Sleep med OP Prog note | |||||||
| 100532-1 | SW OP Prog note | |||||||
| 100533-9 | Solid Org Transplant OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. transplantatie van solide orgaan (document) | ||||||
| 100534-7 | Speech-lang path OP Prog note | |||||||
| 100535-4 | Spinal surgery OP Prog note | |||||||
| 100536-2 | Sports medicine OP Prog note | |||||||
| 10053-7 | S wave dur L-V2 | duración de la onda S.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V2 | ||||
| 100537-0 | Hand Surgery OP Prog note | |||||||
| 100538-8 | Telehealth+Outpatient Prog note | |||||||
| 100539-6 | Thromboemb OP Prog note | |||||||
| 100540-4 | Transpl surg OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. transplantatiechirurgie (document) | ||||||
| 100541-2 | Trauma OP Prog note | |||||||
| 100542-0 | Urology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. urologie (document) | ||||||
| 100543-8 | Vasc Neuro OP Prog note | |||||||
| 100544-6 | Vascular surgery OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. vaatchirurgie (document) | ||||||
| 10054-5 | S wave dur L-V3 | duración de la onda S.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V3 | ||||
| 100545-3 | Wound care management OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. wondzorg (document) | ||||||
| 100546-1 | WOC OP Prog note | |||||||
| 100547-9 | Adolescent med Hosp Prog note | |||||||
| 100548-7 | Allergy+Immunology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. allergie+immunologie (document) | ||||||
| 100549-5 | Allergy Hosp Prog note | |||||||
| 100550-3 | Attend Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. behandelend arts (document) | ||||||
| 100551-1 | Audiology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. audiologie (document) | ||||||
| 10055-2 | S wave dur L-V4 | duración de la onda S.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V4 | ||||
| 100552-9 | Bariatric surg Hosp Prog note | |||||||
| 100553-7 | Bld Bnk+Trans Med Hosp Prog note | |||||||
| 100554-5 | BM Transplant Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. beenmergtransplantatie (document) | ||||||
| 100555-2 | Breastfeeding Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. borstvoeding (document) | ||||||
| 100556-0 | Burn Hosp Prog note | |||||||
| 100557-8 | Cardiac surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. cardiochirurgie (document) | ||||||
| 100558-6 | Cardio+Pulm disease Hosp Prog note | |||||||
| 100559-4 | Child+teen psych Hosp Prog note | |||||||
| 10056-0 | S wave dur L-V5 | duración de la onda S.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V5 | ||||
| 100560-2 | Electrophysiology Hosp Prog note | |||||||
| 100561-0 | Clinical genetics Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. klinische genetica (document) | ||||||
| 100562-8 | Clinical Neurophys Hosp Prog note | |||||||
| 100563-6 | Clin Path Hosp Prog note | |||||||
| 100564-4 | Col+rec surg Hosp Prog note | |||||||
| 100565-1 | Consultant Hosp Prog note | |||||||
| 100566-9 | Dentistry Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. tandheelkunde (document) | ||||||
| 100567-7 | Dermatology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. dermatologie (document) | ||||||
| 100568-5 | Develop-behav peds Hosp Prog note | |||||||
| 100569-3 | Dialy+Ther Apher Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. dialyse en therapeutische aferese (document) | ||||||
| 100570-1 | Eating disorders Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. eetstoornis (document) | ||||||
| 100571-9 | Endocrinology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. endocrinologie (document) | ||||||
| 100572-7 | Fam Med Hosp Prog note | |||||||
| 100573-5 | Gastroenterology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. gastro-enterologie (document) | ||||||
| 100574-3 | General medicine Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. algemene geneeskunde (document) | ||||||
| 100575-0 | Geri med Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. geriatrie (document) | ||||||
| 100576-8 | Gyn Onc Hosp Prog note | |||||||
| 100577-6 | Gynecology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. gynaecologie (document) | ||||||
| 10057-8 | S wave dur L-V6 | duración de la onda S.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V6 | ||||
| 100578-4 | Navigator Hosp Prog note | |||||||
| 100579-2 | Heart failure Hosp Prog note | |||||||
| 1005-8 | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo específico de IgG [Inmunoglobulina G]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | Prueba de antiglobulina indirecta Reactivo específico IgG: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | Test indirect à l'antiglobuline (TIA) IgG spécifique [Présence/Seuil] Sérum/Plasma ; Qualitatif | Indirecte antiglobulinetest.IgG-specifiek reagent [aanwezigheid] in serum of plasma | IAT IgG-Sp Reag SerPl Ql | ||
| 100580-0 | HF+TC Hosp Prog note | |||||||
| 100581-8 | Hematology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. hematologie (document) | ||||||
| 100582-6 | HemOnc Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. hematologie + oncologie (document) | ||||||
| 100583-4 | Hepatology Hosp Prog note | |||||||
| 100584-2 | Immunology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. immunologie (document) | ||||||
| 100585-9 | Infectious disease Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. infectioloog (document) | ||||||
| 10058-6 | S' wave Amp L-AVF | amplitud de la onda S'.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-AVF | ||||
| 100586-7 | Internal Med Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. interne geneeskunde (document) | ||||||
| 100587-5 | IC Hosp Prog note | |||||||
| 100588-3 | IR Hosp Prog note | |||||||
| 100589-1 | Hosp MCS+progress note | |||||||
| 100590-9 | MAiD Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. medische zorg bij sterven (document) | ||||||
| 100591-7 | Mental health Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. geestelijke gezondheidszorg (document) | ||||||
| 100592-5 | Multi-spec prog Hosp Prog note | |||||||
| 100593-3 | Neo peri med Hosp Prog note | |||||||
| 10059-4 | S' wave Amp L-AVL | amplitud de la onda S'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-AVL | ||||
| 100594-1 | Nephrology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. nefrologie (document) | ||||||
| 100595-8 | Neuro surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. neurochirurgie (document) | ||||||
| 100596-6 | Neurology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. neurologie (document) | ||||||
| 100597-4 | Child neuro Hosp Prog note | |||||||
| 100598-2 | Nurse pract Hosp Prog note | |||||||
| 100599-0 | Nurse Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. verpleegkundige (document) | ||||||
| 100600-6 | Nutr+diet Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. voeding en diëtetiek (document) | ||||||
| 100601-4 | OBGYN Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. obstetrie en gynaecologie (document) | ||||||
| 10060-2 | S' wave Amp L-AVR | amplitud de la onda S'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-AVR | ||||
| 100602-2 | OB Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. obstetrie (document) | ||||||
| 100603-0 | OT Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. bezigheidstherapie (document) | ||||||
| 100604-8 | Oncology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oncologie (document) | ||||||
| 100605-5 | Ophthalmol Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oogheelkunde (document) | ||||||
| 100606-3 | OMS Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oromaxillofaciale chirurgie (document) | ||||||
| 100607-1 | Orthopaedic surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. orthopedische chirurgie (document) | ||||||
| 100608-9 | Orthotics prosthetics Hosp Prog note | |||||||
| 100609-7 | Otolaryngology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. KNO (document) | ||||||
| 10061-0 | S' wave Amp L-I | amplitud de la onda S'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-I | ||||
| 100610-5 | Pain medicine Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. pijnbestrijding (document) | ||||||
| 100611-3 | Palliative care Hosp Prog note | |||||||
| 100612-1 | Pastoral Care Hosp Prog note | |||||||
| 100613-9 | Peds cardiology Hosp Prog note | |||||||
| 100614-7 | Peds dermatology Hosp Prog note | |||||||
| 100615-4 | Peds endocrinology Hosp Prog note | |||||||
| 100616-2 | Peds gastroenterology Hosp Prog note | |||||||
| 100617-0 | Peds hem-onc Hosp Prog note | |||||||
| 100618-8 | Peds infect disease Hosp Prog note | |||||||
| 100619-6 | Peds otolaryngology Hosp Prog note | |||||||
| 100620-4 | Peds pulmonology Hosp Prog note | |||||||
| 100621-2 | Peds rheumatology Hosp Prog note | |||||||
| 100622-0 | Peds surgery Hosp Prog note | |||||||
| 100623-8 | Peds transpl hepato Hosp Prog note | |||||||
| 100624-6 | Pharmacogenomics Hosp Prog note | |||||||
| 100625-3 | Pharmacology Hosp Prog note | |||||||
| 100626-1 | PM+R Hosp Prog note | |||||||
| 100627-9 | PT Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. fysiotherapie (document) | ||||||
| 10062-8 | S' wave Amp L-II | amplitud de la onda S'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-II | ||||
| 100628-7 | Plastic surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. plastische chirurgie (document) | ||||||
| 100629-5 | Podiatry Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. podologie (document) | ||||||
| 100630-3 | Psych Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. psychologie (document) | ||||||
| 100631-1 | Radiation Onc Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. radiotherapie (document) | ||||||
| 100632-9 | Radiology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. radiologie (document) | ||||||
| 100633-7 | Rapid response team Hosp Prog note | |||||||
| 100634-5 | Rec therapy Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. recreationele therapie (document) | ||||||
| 100635-2 | REI Hosp Prog note | |||||||
| 10063-6 | S' wave Amp L-III | amplitud de la onda S'.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-III | ||||
| 100636-0 | Research Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. wetenschappelijk onderzoek (document) | ||||||
| 100637-8 | Rheumatology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. reumatologie (document) | ||||||
| 100638-6 | Sleep med Hosp Prog note | |||||||
| 100639-4 | SW Hosp Prog note | |||||||
| 100640-2 | Solid Org Transplant Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. transplantatie van solide orgaan (document) | ||||||
| 100641-0 | Speech-lang path Hosp Prog note | |||||||
| 100642-8 | Spinal surgery Hosp Prog note | |||||||
| 100643-6 | Hand Surgery Hosp Prog note | |||||||
| 10064-4 | S' wave Amp L-V1 | amplitud de la onda S'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V1 | ||||
| 100644-4 | Thromboemb Hosp Prog note | |||||||
| 100645-1 | Trauma Hosp Prog note | |||||||
| 100646-9 | Urology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. urologie (document) | ||||||
| 100647-7 | Vasc Neuro Hosp Prog note | |||||||
| 100648-5 | Vascular surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. vaatchirurgie (document) | ||||||
| 100649-3 | Wound care management Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. wondzorg (document) | ||||||
| 100650-1 | WOC Hosp Prog note | |||||||
| 10065-1 | S' wave Amp L-V2 | amplitud de la onda S'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V2 | ||||
| 100651-9 | Hosp COVID-19 Intub+Progress | |||||||
| 100652-7 | Pure tone bone thresh Pnl | |||||||
| 100653-5 | Pure tone air thresh Pnl | |||||||
| 100654-3 | M2-PK (Pyruvatkinase) /Stuhl | Pyruvate kinase M2, Stool | Pyruvate kinase M2 [Présence/Seuil] Selle ; Qualitatif | Pyruvaatkinase M2 [aanwezigheid] in feces | ||||
| 100655-0 | XR ST Lat | |||||||
| 100656-8 | Mat fetal med OP Prog note | |||||||
| 100657-6 | Mat fetal med Phone+Hosp Prog note | |||||||
| 100658-4 | Hosp COVID-19 Progress note | |||||||
| 100659-2 | Mat fetal med Hosp Prog note | |||||||
| 1006-6 | Direkt-Antiglobulintest.IgG-spezifisches Reagenz [Interpretation] auf Erythrozyten | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo específico de IgG [Inmunoglobulina G]:impresión/interpretación del estudio:punto en el tiempo:eritrocitos:Nominal: | Prueba de antiglobulina directa Reactivo específico IgG: Eritrocitos : Punto temporal: Impresión / interpretación del estudio: Nominal: | Test direct à l'antiglobuline (EDA) IgG spécifique [Interprétation] Érythrocytes ; Résultat nominal | Directe antiglobulinetest.IgG specifiek reagens [interpretatie] in erytrocyten | DAT IgG-Sp Reag RBC-Imp | |
| 100660-0 | Mat fetal med Phone+OP Prog note | |||||||
| 100661-8 | Psychiatric OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. psychiatrie (document) | ||||||
| 100662-6 | Cortisol free and total panel, Blood | Cortisol libre et total panel [-] Sérum/Plasma ; - | Cortisol vrij & totaal panel in serum of plasma | |||||
| 100663-4 | TPMT gene c.460G>A&c.719A>G, Blood | TPMT gène c.460G>A et c.719A>G [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | TPMT-gen c.460G>A&c.719A>G [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100664-2 | NUDT15 gene c.50_55dup&c.415C>T, Blood | NUDT15 gène c.50_55dup et c.415C>T [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.50_55dup&c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100665-9 | NUDT15 gene c.415C>T, Blood | NUDT15 gène c.415C>T [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100666-7 | NUDT15 gene c.52G>A, Blood | NUDT15 gène c.416G>A [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.416G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100667-5 | NUDT15 gene c.52G>A, Blood | NUDT15 gène c.52G>A [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.52G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100668-3 | NUDT15 gene c.50_55dup, Blood | NUDT15 gène c.50_55dup [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.50_55dup [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 10066-9 | S' wave Amp L-V3 | amplitud de la onda S'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V3 | ||||
| 100669-1 | NUDT15 gene c.50_55del, Blood | NUDT15 gène c.50_55del [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.50_55del [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100670-9 | Fetal RHD gene allele--fetus | RHD gène allèle du fœtus [Identification] Plasma avec ADN libre circulant ; Résultat nominal | RHD-allel^foetus [identificator] in plasma.celvrij DNA | |||||
| 100671-7 | Aspergillus sp, Blood | Aspergillus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cible | Aspergillus sp. DNA [aanwezigheid] in bloed d.m.v. probe-detectie | |||||
| 100672-5 | Aspergillus fumigatus, Blood | Aspergillus fumigatus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cible | Aspergillus fumigatus DNA [aanwezigheid] in bloed d.m.v. probe-detectie | |||||
| 100673-3 | Aspergillus terreus, Blood | Aspergillus terreus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cible | Aspergillus terreus DNA [aanwezigheid] in bloed d.m.v. probe-detectie | |||||
| 100674-1 | BK virus, Blood | BK virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | BK-virus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
| 100675-8 | Cytomegalie-Virus DNA [Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Cytomegalovirus (CMV), Blood | Cytomégalovirus ADN [Arbitraire/Volume] Sang ; Numérique ; PCR amplification de cible | Cytomegalovirus DNA [eenheid/volume] in bloed d.m.v. probe-detectie | ||||
| 100676-6 | Cytomegalie-Virus DNA [log Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Cytomegalovirus (CMV), Blood | Cytomégalovirus ADN [Log arbitraire/Volume] Sang ; Numérique ; PCR amplification de cible | Cytomegalovirus DNA [logaritmische eenheid/volume] in bloed d.m.v. probe-detectie | ||||
| 10067-7 | S' wave Amp L-V4 | amplitud de la onda S'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V4 | ||||
| 100677-4 | Epstein Barr virus (EBV), Blood | Epstein barr virus ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible | Epstein-Barr-virus DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
| 100678-2 | Epstein Barr virus (EBV), Blood | Epstein barr virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | Epstein-Barr-virus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
| 100679-0 | Herpes virus (HHV) 6, Blood | Herpes virus 6 ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible | Humaan betaherpesvirus type 6 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
| 100680-8 | Herpes virus (HHV) 6, Blood | Herpes virus 6 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | Humaan betaherpesvirus type 6 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
| 100681-6 | Herpes virus (HHV) 7, Blood | Herpes virus 7 ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible | Humaan betaherpesvirus type 7 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
| 100682-4 | Herpes virus (HHV) 7, Blood | Herpes virus 7 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | Humaan betaherpesvirus type 7 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
| 100683-2 | Herpes virus (HHV) 8, Blood | Herpes virus 8 ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible | Humaan herpesvirus 8 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
| 100684-0 | Herpes virus (HHV) 8, Blood | Herpes virus 8 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | Humaan herpesvirus 8 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
| 10068-5 | S' wave Amp L-V5 | amplitud de la onda S'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V5 | ||||
| 100685-7 | JC virus, Blood | JC virus ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible | JC-virus DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
| 100686-5 | JC virus, Spinal fluid | JC virus ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cible | JC-virus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | |||||
| 100687-3 | JC virus, Urine | JC virus ADN [Log Nombre/Volume] Urine ; Numérique ; PCR amplification de cible | JC-virus DNA [logaritmisch aantal/volume] in urine d.m.v. probe-detectie | |||||
| 100688-1 | Parvovirus B19 DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Parvovirus B19, Blood | Parvovirus B19 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | Parvovirus B19 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | ||||
| 100689-9 | Toxoplasma gondii DNA [log #/Volumen] in Serum oder Plasma mittels Nukleinsäureamplifikation mit Sondendetektion | Toxoplasma gondii, Blood | Toxoplasma gondii ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible | Toxoplasma gondii DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | ||||
| 100690-7 | Toxoplasma gondii DNA [log #/Volumen] in Liquor mittels Nukleinsäureamplifikation mit Sondendetektion | Toxoplasma gondii, Spinal fluid | Toxoplasma gondii ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cible | Toxoplasma gondii DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | ||||
| 100691-5 | Varicella-Zoster-Virus DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Varicella zoster virus (VZV; Chickenpox), Blood | Varicelle zona virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | Varicella-zostervirus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | ||||
| 100692-3 | Varicella-Zoster-Virus DNA [log #/Volumen] (Viruslast) in Liquor mittels Nukleinsäureamplifikation mit Sondendetektion | Varicella zoster virus (VZV; Chickenpox), Spinal fluid | Varicelle zona virus ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cible | Varicella-zostervirus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | ||||
| 10069-3 | S' wave Amp L-V6 | amplitud de la onda S'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V6 | ||||
| 100693-1 | Pneumocystis jiroveci, Respiratory system specimen | Pneumocystis jiroveci ADN [Log Nombre/Volume] Respiratoire ; Numérique ; PCR amplification de cible | Pneumocystis jiroveci DNA [logaritmisch aantal/volume] in respiratoir monster d.m.v. probe-detectie | |||||
| 100694-9 | SMN1 gene silent carrier analysis, Blood or tissue specimen | SMN1 gène analyse des porteurs silencieux [Présence/Seuil] Sang/Tissu ; Qualitatif ; Biologie moléculaire | Stille drager van SMN1-gen analyse [aanwezigheid] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100695-6 | Genetic disease analysis overall carrier interpretation, Blood or tissue specimen | Maladie génétique transmise interprétation globale [Interprétation] Sang/Tissu ; Résultat textuel ; Biologie moléculaire | ||||||
| 100696-4 | CTNS related multigene analysis, Body Fld+S/P | Analyse multigénique en relation avec le CTNS [Identification] Liquide biologique+Sérum/Plasma ; Résultat nominal ; Biologie moléculaire | CTNS-gerelateerde multigen-analyse [identificator] in lichaamsvloeistof en serum of plasma d.m.v. moleculair genetisch onderzoek | |||||
| 100697-2 | IR OP Note | |||||||
| 100698-0 | SDOH screen report Doc | |||||||
| 100699-8 | Susceptibility to Rifabutin+Ethambutol | Rifabutine+éthambutol [Sensibilité] Isolat ; Alphanumérique | Rifabutine + ethambutol [gevoeligheid] in isolaat | |||||
| 100700-4 | Trichomonas vaginalis, Urethra | Trichomonas vaginalis ADN [Présence/Seuil] Urètre ; Qualitatif ; PCR amplification de cible | Trichomonas vaginalis DNA [aanwezigheid] in urethra d.m.v. probe-detectie | |||||
| 10070-1 | S' wave dur L-AVF | duración de la onda S'.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-AVF | ||||
| 100701-2 | Trichomonas vaginalis, Urethra | Trichomonas vaginalis ARNr [Présence/Seuil] Urètre ; Qualitatif ; PCR amplification de cible | Trichomonas vaginalis rRNA [aanwezigheid] in urethra d.m.v. probe-detectie | |||||
| 100702-0 | Mycoplasma genitalium rRNA [Nachweis] in Harnröhre mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Urethra | Mycoplasma genitalium ARNr [Présence/Seuil] Urètre ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] in urethra d.m.v. probe-detectie | ||||
| 100703-8 | Mycoplasma genitalium rRNA [Nachweis] in Urin mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Urine | Mycoplasma genitalium ARNr [Présence/Seuil] Urine ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] in urine d.m.v. probe-detectie | ||||
| 100704-6 | Mycoplasma genitalium rRNA [Nachweis] in Zervix mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Cervix | Mycoplasma genitalium ARNr [Présence/Seuil] Col de l'utérus ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] in cervix d.m.v. probe-detectie | ||||
| 100705-3 | Mycoplasma genitalium rRNA [Nachweis] in anorektalem Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Anorectal | Mycoplasma genitalium ARNr [Présence/Seuil] Anorectal ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] in anorectaal d.m.v. probe-detectie | ||||
| 100706-1 | Mycoplasma genitalium rRNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Specimen | Mycoplasma genitalium ARNr [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] d.m.v. probe-detectie | ||||
| 100707-9 | Polymorphonuclear cells, Peritoneal dialysis fluid | Cellules polymorphonucléaires [Nombre/Volume] Liquide de dialyse péritonéale ; Numérique ; Comptage automate | Polymorfonucleaire cellen [aantal/volume] in periteonale dialysevloeistof d.m.v. geautomatiseerde telling | |||||
| 100708-7 | Plasma cells per 100 white blood cells, Synovial fluid | Plasmocytes/100 leucocytes [Fraction de nombres] Liquide synovial ; Numérique | Plasmacellen/100 leukocyten [getalsfractie] in synoviaal vocht | |||||
| 100709-5 | Hepatocellular carcinoma risk | Risque de cancer hépatocellulaire [Score] Patient ; Numérique ; GAAD | Risico op hepatocellulair carcinoom [score] d.m.v. GAAD-score | |||||
| 100710-3 | Chlamydia trachomatis and Neisseria gonorrhoeae panel, Throat | Chlamydia trachomatis et Neisseria gonorrhoeae ARNr panel [-] Gorge ; - ; PCR amplification de cible | Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel in keel d.m.v. probe-detectie | |||||
| 100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Antikörper [Einheiten/Volumen] in Serum mittels Immunoassay | Borrelia burgdorferi.VlsE1+pepC10 antibody, Blood | Borrelia burgdorferi VlsE1+pepC10 Ac [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse | Borrelia burgdorferi.VlsE1+pepC10 As [eenheid/volume] in serum d.m.v. immunoassay | ||||
| 100712-9 | Brexpiprazole, Blood | Brexpiprazole [Masse/Volume] Sérum/Plasma ; Numérique | Brexpiprazol [massa/volume] in serum of plasma | |||||
| 100713-7 | Cariprazine, Blood | Cariprazine [Masse/Volume] Sérum/Plasma ; Numérique | Cariprazine [massa/volume] in serum of plasma | |||||
| 100714-5 | Guanfacine, Blood | Guanfacine [Masse/Volume] Sérum/Plasma ; Numérique | Guanfacine [massa/volume] in serum of plasma | |||||
| 100715-2 | Prothipendyl, Blood | Prothipendyl [Masse/Volume] Sérum/Plasma ; Numérique | Prothipendyl [massa/volume] in serum of plasma | |||||
| 100716-0 | Prostate specific antigen, Dried blood spot | Prostate spécifique antigène [Masse/Volume] Sang buvard ; Numérique | Prostaatspecifiek Ag [massa/volume] in gedroogde bloedspot | |||||
| 100717-8 | FCGR3A gene.p.Phe176Val, Blood or tissue specimen | FCGR3A gène p.Phe176Val [Présence/Seuil] Sang/Tissu ; Qualitatif ; Biologie moléculaire | FCGR3A-gen.p.Phe176Val [aanwezigheid] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100718-6 | Undersea+hyperbar D/C sum | |||||||
| 10071-9 | S' wave dur L-AVL | duración de la onda S'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Liderar AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-AVL | ||||
| 100719-4 | Surg Onc D/C sum | |||||||
| 100720-2 | REI D/C sum | |||||||
| 100721-0 | Comm hlth care D/C sum | |||||||
| 100722-8 | Integrative medicine D/C sum | |||||||
| 100723-6 | Sports medicine D/C sum | |||||||
| 100724-4 | Diabetology D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. diabetologie (document) | ||||||
| 100725-1 | Optometry D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. optometrie (document) | ||||||
| 100726-9 | Podiatry D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. podologie (document) | ||||||
| 10072-7 | S' wave dur L-AVR | duración de la onda S'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. adelantar AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-AVR | ||||
| 100727-7 | Chiropractic med D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. chiropractie (document) | ||||||
| 100728-5 | Cardiac surgery D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. cardiochirurgie (document) | ||||||
| 100729-3 | Breastfeeding D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. borstvoeding (document) | ||||||
| 100730-1 | Transpl surg D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. transplantatiechirurgie (document) | ||||||
| 100731-9 | Urgent care D/C sum | |||||||
| 100732-7 | Cholesterol.in lipoprotein (little a) & Cholesterol.in LDL panel, Blood | Cholesterol Lp(a) et cholesterol LDL panel [-] Sérum ; - | Cholesterol.in lipoproteïne (kleine a) & cholesterol.in LDL panel in serum | |||||
| 100733-5 | LDL cholesterol corrected for Cholesterol.in lipoprotein (little a), Blood | Cholestérol LDL corrigé par cholestérol Lp(a) [Masse/Volume] Sérum ; Numérique ; Résultat calculé | Cholesterol.in LDL^gecorrigeerd voor cholesterol.in lipoproteïne (kleine a) [massa/volume] in serum d.m.v. berekend | |||||
| 100734-3 | traMADol and Metabolites Panel, Urine | Tramadol et métabolites panel [-] Urine ; - ; Confirmation | Tramadol & metabolieten panel in urine d.m.v. bevestiging | |||||
| 10073-5 | S' wave dur L-I | duración de la onda S'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-I | ||||
| 100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel, White blood cells | Mannose-6-phosphate isomérase et phosphomannomutase 1 panel [-] Leucocytes ; - | Mannose-6-fosfaatisomerase & fosfomannomutase 1 panel in leukocyten | |||||
| 100736-8 | Acylcarnitine Analysis Post Mortem, Specimen | Acylcarnitine post-mortem [Recherche] Milieux divers ; Document | Acylcarnitine postmortale analyse [bevinding] (document) | |||||
| 100737-6 | Alkaline phosphatase.macromolecular, Blood | Phosphatase alcaline macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Alkalinefosfatase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 100738-4 | Macromolecular alanine aminotransferase, Blood | Alanine aminotransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Alanine-aminotransferase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 100739-2 | Macromolecular aspartate aminotransferase, Blood | Aspartate aminotransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Aspartaataminotransferase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 1007-4 | DCT polyspez. | Direkt-Antiglobulintest.polyspezifisches Reagenz [Nachweis] auf Erythrozyten | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo poliespecífico:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: | Prueba de antiglobulina directa, reactivo específico de poli: Eritrocitos : Punto temporal: Presencia o umbral: Ordinal: | Test direct à l'antiglobuline (EDA) polyvalente [Présence/Seuil] Érythrocytes ; Qualitatif | Directe antiglobulinetest.polyspecifiek reagens [aanwezigheid] in erytrocyten | DAT Poly-Sp Reag RBC Ql |
| 100740-0 | Amylase.macromolecular, Blood | Amylase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Amylase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 100741-8 | Gamma glutamyl transferase.macromolecular, Blood | Gamma glutamyltransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Gamma-glutamyltransferase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 100742-6 | Lactate dehydrogenase.macromolecular, Blood | Lactate déhydrogénase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Lactaatdehydrogenase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 10074-3 | S' wave dur L-II | duración de la onda S'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-II | ||||
| 100743-4 | Lipase.macromolecular, Blood | Lipase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Lipase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 100744-2 | Alpha-1-acid glycoprotein, Blood | Orosomucoïde [Masse/Volume] Sérum/Plasma ; Numérique ; Électrophorèse | Alfa-1-zure glycoproteïne [massa/volume] in serum of plasma d.m.v. elektroforese | |||||
| 100745-9 | Chloride, Blood | Chlore [Moles/Volume] Sang mêlé veineux ; Numérique | Chloride [mol/volume] in gemengd veneus bloed | |||||
| 100746-7 | Glucose, Blood | Glucose [Moles/Volume] Sang mêlé veineux ; Numérique | Glucose [mol/volume] in gemengd veneus bloed | |||||
| 100747-5 | Legionella serogroup panel, Specimen | Legionella sérogroupe panel [-] Milieux divers ; - | Legionella serogroep panel | |||||
| 100748-3 | Legionella spp [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella spp, Specimen | Legionella spp [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Legionella spp. [aanwezigheid] d.m.v. probe-detectie | ||||
| 100749-1 | Legionella pneumophila, Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella pneumophila serogroup 1, Specimen | Legionella pneumophila sérogroupe 1 [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Legionella pneumophila serogroep 1 [aanwezigheid] d.m.v. probe-detectie | ||||
| 10075-0 | S' wave dur L-III | duración de la onda S'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-III | ||||
| 100750-9 | Legionella pneumophila, nicht Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella pneumophila non-serogroup 1, Specimen | Legionella pneumophila non sérogroupe 1 [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Legionella pneumophila anders dan serogroep 1 [aanwezigheid] d.m.v. probe-detectie | ||||
| 100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel, Blood | Galactose-alpha-1,3-galactose panel [-] Sérum/Plasma ; - | Galactose-alfa-1,3-galactose panel in serum of plasma | |||||
| 100752-5 | Exacerbating factors Reported | |||||||
| 100753-3 | Alleviating factors Reported | |||||||
| 100754-1 | Platelet disorders multigene analysis, Blood or tissue specimen | Analyse multigénique des troubles plaquettaires [Recherche] Sang/Tissu ; Document ; Séquençage | Trombocytopathie multigen-analyse [bevinding] in bloed of weefsel d.m.v. sequencing (document) | |||||
| 100755-8 | Oligoclonal bands, Blood | Protéines fractions oligoclonales [Nombre] Sérum/Plasma ; Numérique ; Isoélectrofocalisation | Eiwitfracties.oligoklonale banden [aantal] in serum of plasma d.m.v. iso-elektrisch focusseren | |||||
| 100756-6 | Oligoclonal bands, Spinal fluid | Protéines fractions oligoclonales [Interprétation] Liquide céphalorachidien ; Résultat nominal ; Isoélectrofocalisation | Eiwitfracties.oligoklonale banden [interpretatie] in liquor cerebrospinalis d.m.v. iso-elektrisch focusseren | |||||
| 100757-4 | Protein fractions.oligoclonal bands panel, Serum+Cerebrospinal fluid | Protéines fractions oligoclonales panel [-] Sérum+Liquide céphalorachidien ; - ; Isoélectrofocalisation | Eiwitfracties.oligoklonale banden panel in serum en liquor cerebrospinalis d.m.v. iso-elektrisch focusseren | |||||
| 100758-2 | Estimated lung age from clin data | |||||||
| 100759-0 | Inspiratory reserve vol spirometry | |||||||
| 100760-8 | XR Radius+Ulna-L 1V | |||||||
| 100761-6 | PALB2 gene targeted mutation analysis, Blood or tissue specimen | PALB2 gène mutation cible trouvée [Recherche] Sang/Tissu ; Document ; Biologie moléculaire | PALB2-gen doelgerichte mutatie-analyse [bevinding] in bloed of weefsel d.m.v. moleculair genetisch onderzoek (document) | |||||
| 100762-4 | HBA2 gene.c.377T>C, Blood | HBA2 gène c.377T>C [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | HBA2-gen.c.377T>C [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100763-2 | Mycobacterium sp comparative reaction interpretation, Skin | Comparatieve reactie op Mycobacterium sp. Interpretatie [interpretatie] in huid (tekstueel) | ||||||
| 100764-0 | Mycobacterium bovis reaction wheal 3 days after Mammalian Tuberculin Intradermal, Skin | Mycobacterium bovis huidreactie^3 dagen na dosis zoogdiertuberculine ID [diameter] in huid | ||||||
| 100765-7 | Homocysteine and Methylmalonate and Methylcitrate panel, Dried blood spot | Homocystéine et méthylmalonate et 2-méthylcitrate panel [-] Sang buvard ; - | Homocysteïne & methylmalonaat & 2-methylcitraat panel in gedroogde bloedspot | |||||
| 100766-5 | Center for Epidemiologic Studies Depression Scale panel [CES-D] | |||||||
| 100767-3 | Bothered by things that are not usually bothersome | |||||||
| 10076-8 | S' wave dur L-V1 | duración de la onda S'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V1 | ||||
| 100768-1 | Poor appetite | |||||||
| 100769-9 | Unhappy even with help from my family or friends | |||||||
| 100770-7 | Feeling just as good as others | |||||||
| 100771-5 | Trouble focusing | |||||||
| 100772-3 | Feeling depressed | |||||||
| 100773-1 | Feeling everything is too much of an effort | |||||||
| 100774-9 | Feeling hopeful about the future | |||||||
| 100775-6 | Feeling life had been a failure | |||||||
| 10077-6 | S' wave dur L-V2 | duración de la onda S'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V2 | ||||
| 100776-4 | Feeling fearful | |||||||
| 100777-2 | Restless sleep | |||||||
| 100778-0 | Feeling happy | |||||||
| 100779-8 | Quieter than usual | |||||||
| 100780-6 | Feeling lonely | |||||||
| 100781-4 | People were unfriendly | |||||||
| 100782-2 | Enjoying life | |||||||
| 100783-0 | Crying spells | |||||||
| 10078-4 | S' wave dur L-V3 | duración de la onda S'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V3 | ||||
| 100784-8 | Feeling sad | |||||||
| 100785-5 | Feeling people dislike me | |||||||
| 100786-3 | Lack of energy | |||||||
| 100787-1 | Total Score CES-D | |||||||
| 100788-9 | Stemphylium botryosum IgG4 antibody | Stemphylium botryosum Ac IgG4 [Masse/Volume] Sérum ; Numérique | Stemphylium botryosum As.IgG4 [massa/volume] in serum | |||||
| 100789-7 | Rhizopus nigricans IgG4 antibody | Rhizopus nigricans Ac IgG4 [Masse/Volume] Sérum ; Numérique | Rhizopus nigricans As.IgG4 [massa/volume] in serum | |||||
| 100790-5 | Lepidoglyphus destructor IgG antibody | Lepidoglyphus destructor Ac IgG [Masse/Volume] Sérum ; Numérique | Lepidoglyphus destructor As.IgG [massa/volume] in serum | |||||
| 100791-3 | Hamster epithelium IgG antibody | Hamster (épithélium) Ac IgG [Masse/Volume] Sérum ; Numérique | Hamsterepitheel As.IgG [massa/volume] in serum | |||||
| 10079-2 | S' wave dur L-V4 | duración de la onda S'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V4 | ||||
| 100792-1 | Forsythia allergy test | Forsythia Ac IgE [Arbitraire/Volume] Sérum ; Numérique | Forsythia As.IgE [eenheid/volume] in serum | |||||
| 100793-9 | Testosterone, Body fluid | Testostérone [Masse/Volume] Liquide biologique ; Numérique | Testosteron [massa/volume] in lichaamsvocht | |||||
| 100794-7 | Follitropin (FSH; Follicle Stimulating Hormone), Body fluid | Folliculostimuline [Arbitraire/Volume] Liquide biologique ; Numérique | Follikelstimulerend hormoon [eenheid/volume] in lichaamsvocht | |||||
| 100795-4 | S100 Calcium Binding Protein B, Body fluid | Protéine S100B [Masse/Volume] Liquide biologique ; Numérique | S100 calciumbindend eiwit B [massa/volume] in lichaamsvocht | |||||
| 100796-2 | Thyroglobulin, Body fluid | Thyroglobuline [Masse/Volume] Liquide biologique ; Numérique | Thyreoglobuline [massa/volume] in lichaamsvocht | |||||
| 100797-0 | Free testosterone 1st specimen after challenge, Blood | Testostérone libre T01 après épreuve [Masse/Volume] Sérum ; Numérique | Testosteron.vrij^1ste monster na XXX belasting [massa/volume] in serum | |||||
| 100798-8 | Free testosterone 2nd specimen after challenge, Blood | Testostérone libre T02 après épreuve [Masse/Volume] Sérum ; Numérique | Testosteron.vrij^2de monster na XXX belasting [massa/volume] in serum | |||||
| 100799-6 | 21-Deoxycortisol 1st specimen after challenge, Blood | 21-déoxycortisol T01 après épreuve [Masse/Volume] Sérum ; Numérique | 21-deoxycortisol^1ste monster na XXX belasting [massa/volume] in serum | |||||
| 100-8 | Cefoperazon [Empfindlichkeit] mittels Bestimmung der minimalen Hemmkonzentration (MHK) | Susceptibility to Cefoperazone | cefoperazona:susceptibilidad:punto en el tiempo:cepa clínica:ordinal o cuantitativo:concentración inhibitoria mínima | Cefoperazona: Aislado : Punto temporal: Susceptibilidad (microorganismos): Ordinal Cuantitativo: Concentración mínima inhibitoria (MIC) | Céfopérazone [Sensibilité] Isolat ; Alphanumérique ; CMI | Cefoperazon [gevoeligheid] in isolaat d.m.v. minimaal inhiberende concentratie | Cefoperazone Islt MIC | |
| 10080-0 | S' wave dur L-V5 | duración de la onda S'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V5 | ||||
| 100800-2 | 21-Deoxycortisol 2nd specimen after challenge, Blood | 21-déoxycortisol T02 après épreuve [Masse/Volume] Sérum ; Numérique | 21-deoxycortisol^2de monster na XXX belasting [massa/volume] in serum | |||||
| 100801-0 | 21-Deoxycortisol 3rd specimen after challenge, Blood | 21-déoxycortisol T03 après épreuve [Masse/Volume] Sérum ; Numérique | 21-deoxycortisol^3de monster na XXX belasting [massa/volume] in serum | |||||
| 100802-8 | 21-Deoxycortisol 4th specimen after challenge, Blood | 21-déoxycortisol T04 après épreuve [Masse/Volume] Sérum ; Numérique | 21-deoxycortisol^4de monster na XXX belasting [massa/volume] in serum | |||||
| 100803-6 | 21-Deoxycortisol 5th specimen after challenge, Blood | 21-déoxycortisol T05 après épreuve [Masse/Volume] Sérum ; Numérique | 21-deoxycortisol^5de monster na XXX belasting [massa/volume] in serum | |||||
| 100804-4 | Vasopressin 1st specimen after challenge, Blood | Vasopressine T01 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^1ste monster na XXX belasting [mol/volume] in plasma | |||||
| 100805-1 | Vasopressin 2nd specimen after challenge, Blood | Vasopressine T02 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^2de monster na XXX belasting [mol/volume] in plasma | |||||
| 100806-9 | Vasopressin 3rd specimen after challenge, Blood | Vasopressine T03 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^3de monster na XXX belasting [mol/volume] in plasma | |||||
| 100807-7 | Vasopressin 4th specimen after challenge, Blood | Vasopressine T04 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^4de monster na XXX belasting [mol/volume] in plasma | |||||
| 100808-5 | Vasopressin 5th specimen after challenge, Blood | Vasopressine T05 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^5de monster na XXX belasting [mol/volume] in plasma | |||||
| 100809-3 | Vasopressin 6th specimen after challenge, Blood | Vasopressine T06 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^6de monster na XXX belasting [mol/volume] in plasma | |||||
| 100810-1 | Vasopressin 7th specimen after challenge, Blood | Vasopressine T07 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^7de monster na XXX belasting [mol/volume] in plasma | |||||
| 100811-9 | Vasopressin 8th specimen after challenge, Blood | Vasopressine T08 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^8ste monster na XXX belasting [mol/volume] in plasma | |||||
| 100812-7 | Vasopressin 9th specimen after challenge, Blood | Vasopressine T09 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^9de monster na XXX belasting [mol/volume] in plasma | |||||
| 100813-5 | Vasopressin 10th specimen after challenge, Blood | Vasopressine T10 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^10de monster na XXX belasting [mol/volume] in plasma | |||||
| 100814-3 | Vasopressin 11th specimen after challenge, Blood | Vasopressine T11 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^11de monster na XXX belasting [mol/volume] in plasma | |||||
| 100815-0 | Vasopressin 12th specimen after challenge, Blood | Vasopressine T12 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^12de monster na XXX belasting [mol/volume] in plasma | |||||
| 100816-8 | Glucagon 6th specimen after challenge, Blood | Glucagon T06 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique | Glucagon^6de monster na XXX belasting [massa/volume] in serum of plasma | |||||
| 100817-6 | Glucagon 7th specimen after challenge, Blood | Glucagon T07 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique | Glucagon^7de monster na XXX belasting [massa/volume] in serum of plasma | |||||
| 10081-8 | S' wave dur L-V6 | duración de la onda S'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V6 | ||||
| 100818-4 | Renin 1st specimen after challenge, Blood | Rénine T01 après épreuve [Masse/Volume] Plasma ; Numérique | Renine^1ste monster na XXX belasting [massa/volume] in plasma | |||||
| 100819-2 | Renin 2nd specimen after challenge, Blood | Rénine T02 après épreuve [Masse/Volume] Plasma ; Numérique | Renine^2de monster na XXX belasting [massa/volume] in plasma | |||||
| 1008-2 | ICT polyspez. | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo multiespecífico:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | Prueba de antiglobulina indirecta, reactivo específico de poli: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | Test indirect à l'antiglobuline (TIA) polyvalente [Présence/Seuil] Sérum/Plasma ; Qualitatif | Indirecte antiglobulinetest.polyspecifiek reagent [aanwezigheid] in serum of plasma | IAT Poly-Sp Reag SerPl Ql | |
| 100820-0 | Renin 3rd specimen after challenge, Blood | Rénine T03 après épreuve [Masse/Volume] Plasma ; Numérique | Renine^3de monster na XXX belasting [massa/volume] in plasma | |||||
| 100821-8 | POLST panel | |||||||
| 100822-6 | Cardiopulmonary resuscitation orders | |||||||
| 100823-4 | Initial portable medical treatment orders | |||||||
| 100824-2 | Additional portable medical orders or instructions | |||||||
| 100825-9 | Medically assisted nutrition orders | |||||||
| 10082-6 | ST I-Amp 6ms L-AVF | amplitud inicial del segmento ST, 6 mseg.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVF | ||||
| 100826-7 | Portable medical order &or advance directive review | |||||||
| 100827-5 | Portable medical order discussion participants | |||||||
| 100828-3 | Portable medical order administrative information | |||||||
| 100829-1 | Renin 4th specimen after challenge, Blood | Rénine T04 après épreuve [Masse/Volume] Plasma ; Numérique | Renine^4de monster na XXX belasting [massa/volume] in plasma | |||||
| 100830-9 | Free alpha subunit 1st specimen after challenge, Blood | Sous unité alpha libre T01 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique | Alfa-subeenheid.vrij^1ste monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100831-7 | Free alpha subunit 2nd specimen after challenge, Blood | Sous unité alpha libre T02 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique | Alfa-subeenheid.vrij^2de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100832-5 | Free alpha subunit 3rd specimen after challenge, Blood | Sous unité alpha libre T03 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique | Alfa-subeenheid.vrij^3de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100833-3 | Free alpha subunit 4th specimen after challenge, Blood | Sous unité alpha libre T04 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique | Alfa-subeenheid.vrij^4de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 10083-4 | ST I-Amp 6ms L-AVL | amplitud inicial del segmento ST, 6 mseg.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVL | ||||
| 100834-1 | Free alpha subunit 5th specimen after challenge, Blood | Sous unité alpha libre T05 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique | Alfa-subeenheid.vrij^5de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100835-8 | Free alpha subunit 6th specimen after challenge, Blood | Sous unité alpha libre T06 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique | Alfa-subeenheid.vrij^6de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100836-6 | Free alpha subunit 7th specimen after challenge, Blood | Sous unité alpha libre T07 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique | Alfa-subeenheid.vrij^7de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100837-4 | Insulin-like growth factor-I 9th specimen after challenge, Blood | Insulin-like growth factor 1 T09 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique | Insulin-like growth factor-I^9de monster na XXX belasting [massa/volume] in serum of plasma | |||||
| 100838-2 | Testosterone 9th specimen after challenge, Blood | Testostérone T09 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique | Testosteron^9de monster na XXX belasting [massa/volume] in serum of plasma | |||||
| 100839-0 | Vitamin A/Retinol binding protein, Blood | Vitamine A/retinol binding protein [Ratio] Sérum/Plasma ; Numérique | Retinol/retinolbindend eiwit [verhouding] in serum of plasma | |||||
| 100840-8 | IgE, Body fluid | Immunoglobuline E [Arbitraire/Volume] Liquide biologique ; Numérique | IgE [eenheid/volume] in lichaamsvocht | |||||
| 100841-6 | Zinc finger protein of the cerebellum 4 antibody, Spinal fluid | Zic4 anticorps [Présence/Seuil] Liquide céphalorachidien ; Qualitatif ; Blot en ligne | Zinc finger proteïne of the cerebellum 4 As [aanwezigheid] in liquor cerebrospinalis d.m.v. lijnblot | |||||
| 10084-2 | ST I-Amp 6ms L-AVR | amplitud inicial del segmento ST, 6 mseg.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms avance AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVR | ||||
| 100842-4 | Nonalcoholic steatohepatitis score, Blood | Stéatohépatite non alcoolique - Score [Score] Sérum/Plasma ; Numérique ; Calculé FAST | ||||||
| 100843-2 | Liver fibrosis score, Blood | Score de fibrose hépatique [Score] Sérum/Plasma ; Numérique ; Calculé par Agile3+ | ||||||
| 100844-0 | Liver fibrosis score, Blood | Score de fibrose hépatique [Score] Sérum/Plasma ; Numérique ; Calculé par Agile4 | ||||||
| 100845-7 | Neurofascin155 IgG4 antibody, Blood | Neurofascine155 Ac IgG4 [Présence/Seuil] Sérum ; Qualitatif ; Cytométrie de flux | Neurofascine155 As.IgG4 [aanwezigheid] in serum d.m.v. flowcytometrie | |||||
| 100846-5 | Dengue-Virus 1+2+3+4 nsP1 IgG IgG-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay | Dengue virus 1+2+3+4 nsP1 IgG antibody, Blood | Dengue virus 1+2+3+4 protéine non structurelle 1 (nsP1) [Présence/Seuil] Sérum/Plasma ; Qualitatif ; Immunoanalyse | Denguevirus 1+2+3+4 niet-structureel proteïne 1 (nsP1) As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay | ||||
| 100847-3 | Gas and ammonia panel, Blood | Gaz du sang et ammoniaque panel [-] Sang artériel ; - | Gas en ammoniak panel in arterieel bloed | |||||
| 100848-1 | Cell count and Differential panel, Amniotic fluid | NFS - Hémogramme panel [-] Liquide amniotique ; - ; Comptage manuel | Celtelling & differentieel panel in vruchtwater d.m.v. manuele telling | |||||
| 100849-9 | White blood cell (WBC) count, Amniotic fluid | Leucocytes [Nombre/Volume] Liquide amniotique ; Numérique ; Comptage manuel | Leukocyten [aantal/volume] in vruchtwater d.m.v. manuele telling | |||||
| 100850-7 | Neutrophils, Amniotic fluid | Polynucléaires neutrophiles [Nombre/Volume] Liquide amniotique ; Numérique ; Comptage manuel | Neutrofielen [aantal/volume] in vruchtwater d.m.v. manuele telling | |||||
| 100851-5 | Other cells, Amniotic fluid | Cellules autres [Nombre/Volume] Liquide amniotique ; Numérique ; Comptage manuel | Overige cellen [aantal/volume] in vruchtwater d.m.v. manuele telling | |||||
| 100852-3 | NM Bones Views for mets W Sr-89 IV | |||||||
| 100853-1 | NM Pericardial effusion | |||||||
| 100854-9 | Lymphocytes per 100 cells, Blood | Lymphocytes/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique ; Immunoanalyse | Lymfocyten/100 cellen [getalsfractie] in mononucleaire cellen in bloed d.m.v. immunoassay | |||||
| 100855-6 | CD3 cells per 100 cells, Blood | CD3/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique | Cellen.CD3/100 cellen [getalsfractie] in mononucleaire cellen in bloed | |||||
| 100856-4 | CD3+CD4+ (T4 Helper) Cells per 100 cells, Blood | CD3+CD4+/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique | Cellen.CD3+CD4+/100 cellen [getalsfractie] in mononucleaire cellen in bloed | |||||
| 100857-2 | CD3+CD8+ (T8 Suppressor) Cells per 100 cells, Blood | CD3+CD8+/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique | Cellen.CD3+CD8+/100 cellen [getalsfractie] in mononucleaire cellen in bloed | |||||
| 100858-0 | Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | CD4+CD154+/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | ||||
| 10085-9 | ST I-Amp 6ms L-I | amplitud inicial del segmento ST, 6 mseg.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-I | ||||
| 100859-8 | Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | CD4 exprimant l'interféron gamma/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | ||||
| 100860-6 | Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | CD4 exprimant le TNF alpha/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | ||||
| 100861-4 | Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nucleokapsid-Peptid | Cells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | CD4+CD154+/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | ||||
| 100862-2 | Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nucleokapsid-Peptid | Cells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | CD4 exprimant l'interféron gamma/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | ||||
| 100863-0 | Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nucleokapsid-Peptid | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | CD4 exprimant le TNF alpha/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | ||||
| 100864-8 | Giardia lamblia bg-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia bg gene genotype, Specimen | Giardia lamblia bg gène [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Giardia lamblia bg-gen [genotype] d.m.v. moleculair genetisch onderzoek | ||||
| 100865-5 | Avian schistosomes, Specimen | Aviaire Schistosoma DNA [aanwezigheid] d.m.v. probe-detectie | ||||||
| 100866-3 | Febrile antibody profile, Blood | Profil d'anticorps fébriles [-] Sérum ; - | ||||||
| 10086-7 | ST I-Amp 6ms L-II | amplitud inicial del segmento ST, 6 mseg.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-II | ||||
| 100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Antigen [Nachweis] in Stuhl mittels Immunoassay-Schnelltest | Campylobacter jejuni+coli+lari+upsaliensis antigen, Stool | Campylobacter jejuni+coli+lari+upsaliensis Ag [Présence/Seuil] Selle ; Qualitatif ; Immunoanalyse rapide | Campylobacter jejuni + coli + lari + upsaliensis Ag [aanwezigheid] in feces d.m.v. immunoassay.sneltest | ||||
| 100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotyp] in Probenmaterial mittels Molekulargenetik | Cryptosporidium sp 18S-LC2 genotype, Specimen | Cryptosporidium 18S-LC2 ARNr [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Cryptosporidium sp. 18S-LC2 rRNA [genotype] d.m.v. moleculair genetisch onderzoek | ||||
| 100869-7 | Cryptosporidium gp60-Gen [Typ] in Probenmaterial mittels Molekulargenetik | Cryptosporidium gp60 gene, Specimen | Cryptosporidium gp60 gène [Type] Milieux divers ; Résultat nominal ; Biologie moléculaire | Cryptosporidium gp60-gen [type] d.m.v. moleculair genetisch onderzoek | ||||
| 100870-5 | Cryptosporidium 18S rRNA [Genotyp] in Probenmaterial mittels Molekulargenetik | Cryptosporidium 18S genotype, Specimen | Cryptosporidium 18S ARNr [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Cryptosporidium 18S rRNA [genotype] d.m.v. moleculair genetisch onderzoek | ||||
| 100871-3 | Giardia lamblia gdh-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia gdh gene genotype, Specimen | Giardia lamblia gdh gène [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Giardia lamblia gdh-gen [genotype] d.m.v. moleculair genetisch onderzoek | ||||
| 100872-1 | Bacteria producing polysaccharide from sucrose | Bactérie productrice de polysaccharide du saccharose [Présence/Seuil] Isolat ; Qualitatif | Uit sucrose polysacharideproducerende bacterie [aanwezigheid] in isolaat | |||||
| 100873-9 | Giardia lamblia tpi-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia tpi gene genotype, Specimen | Giardia lamblia tpi gène [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Giardia lamblia tpi-gen [genotype] d.m.v. moleculair genetisch onderzoek | ||||
| 100874-7 | Basidiobolus sp, Specimen | Basidiobolus [Présence/Seuil] Milieux divers ; Qualitatif | Basidiobolus sp. [aanwezigheid] | |||||
| 10087-5 | ST I-Amp 6ms L-III | amplitud inicial del segmento ST, 6 mseg.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-III | ||||
| 100875-4 | Fet Hrt Doc Ltd US | |||||||
| 100876-2 | Fet Hrt Doc US | |||||||
| 100877-0 | US Heart Transesophageal during surgery | |||||||
| 100878-8 | Endo US study Upr GI Tract Doc | |||||||
| 100879-6 | US Guided Brst-R Cryoablation | |||||||
| 100880-4 | US Guided Brst-L Cryoablation | |||||||
| 100881-2 | MR Guided Bone Cryoablation | |||||||
| 100882-0 | MR Peritoneum W contr percu | |||||||
| 10088-3 | ST I-Amp 6ms L-V1 | amplitud inicial del segmento ST, 6 mseg.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms cable V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | Deprecated ST initial amp 6 ms.lead | ||||
| 100883-8 | MR Guided Kidney-L Bx | |||||||
| 100884-6 | MR Guided Kidney-R Bx | |||||||
| 100885-3 | Parapoxvirus , Specimen | Parapoxvirus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Parapoxvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||
| 100886-1 | Orf virus, Specimen | Orf virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Orfvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||
| 100887-9 | Pseudocowpox virus, Specimen | Pseudocowpox virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Pseudokoepokvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||
| 100888-7 | Affenpocken-Virus Klade II DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus clade II, Specimen | Monkeypox de l'ouest africain virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | 'Mpox'-virus clade II DNA [aanwezigheid] d.m.v. probe-detectie | ||||
| 100889-5 | Affenpocken-Virus Klade I DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus clade I, Specimen | Monkeypox Congo basin virus [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | 'Mpox'-virus clade I DNA [aanwezigheid] d.m.v. probe-detectie | ||||
| 100890-3 | Poxvirus DNA panel | Poxvirus ADN panel [-] Patient ; - | Pokkenvirus DNA panel | |||||
| 10089-1 | ST I-Amp 6ms L-V2 | amplitud inicial del segmento ST, 6 mseg.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms. Derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-V2 | ||||
| 100891-1 | Orthopoxvirus IgG-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay | Orthopoxvirus IgG antibody, Blood | Orthopoxvirus Ac IgG [Présence/Seuil] Sérum/Plasma ; Qualitatif ; Immunoanalyse | Orthopoxvirus As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay | ||||
| 100892-9 | Orthopoxvirus IgM-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay | Orthopoxvirus IgM antibody, Blood | Orthopoxvirus Ac IgM [Présence/Seuil] Sérum/Plasma ; Qualitatif ; Immunoanalyse | Orthopoxvirus As.IgM [aanwezigheid] in serum of plasma d.m.v. immunoassay | ||||
| 100893-7 | Orthopoxvirus IgG & IgM Ab panel, Blood | Orthopoxvirus IgG et IgM Ac panel [-] Sérum/Plasma ; - | Orthopoxvirus IgG & IgM As panel in serum of plasma | |||||
| 100894-5 | Recommended screen freq | |||||||
| 100895-2 | Rickettsia conorii IgG and IgM antibodies, Blood | Rickettsia conorii Ac IgG et IgM [Interprétation] Sérum ; Résultat nominal | Rickettsia conorii As.IgG & IgM [interpretatie] in serum | |||||
| 100896-0 | Vasopressin 13th specimen after challenge, Blood | Vasopressine T13 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^13de monster na XXX belasting [mol/volume] in plasma | |||||
| 100897-8 | Staphylococcus aureus culture, Specimen | Staphylococcus aureus [Présence/Seuil] Milieux divers ; Qualitatif ; Culture spécifique | Staphylococcus aureus [aanwezigheid] d.m.v. organisme-specifieke kweek | |||||
| 100898-6 | Lipid panel, Blood | Lipide panel [-] Sérum/Plasma ; - | Lipiden panel in serum of plasma | |||||
| 100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype culture, Specimen | Enterobacteriaceae phénotype de résistance aux bêta lactamases à spectre élargi [Identification] Milieux divers ; Résultat nominal ; Culture spécifique | Enterobacteriaceae.ESBL-resistentie fenotype [identificator] d.m.v. organisme-specifieke kweek |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
FHIR ®© HL7.org 2011+. FHIR R6 hl7.fhir.core#6.0.0-ballot2 generated on Mon, Aug 12, 2024 16:57+0800.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R5 |
|
Propose a change